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Abstract
Clinicians rely heavily on accurate laboratory results to diagnose and treat their patients.
Laboratory errors can occur in any area of total testing phases, but more than half of the
errors occur in the preanalytical phase. Framed by the total quality management theory,
the purpose of this multiple case study was to explore medical laboratory managers’
strategies to reduce preanalytical errors. A purposive sample of 2 organizations with
laboratories in southern California participated in semistructured face-to-face interviews.
Company A had 2 participants and 3 participants participated in the study from Company
B. Each participant had at least 5 years of laboratory experience, with a minimum of 2
years of management experience in preanalytical testing, and had completed one project
to minimize laboratory errors. Thematic analysis exposed 5 main themes: quality
improvement, recognition, reward, and empowerment, education and training,
communication, and patient satisfaction. The participants highlighted the need for
organizations to concentrate on quality management to achieve patient satisfaction. To
achieve quality services, medical laboratory managers noted the importance of employee
engagement, education and training, and communication as successful strategies to
mitigate preanalytical errors. The recommendation for action is for laboratory leaders to
review and apply effective strategies exposed by the data in this study to reduce
preanalytical errors in their medical laboratory. Positive implications of this study include
reduction of preanalytical errors, increased operational cost, and improved patient
experience.
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Section 1: Foundation of the Study
The Institute of Medicine reported that 1.5 million preventable medical errors
were responsible for anywhere from 44,000 to 98,000 deaths annually in the United
States (Kalra, Kalra, & Baniak, 2013). The cost of medical errors is 45 cents for every
dollar spent. Laboratory medicine plays a pivotal role in the diagnostic process and in
monitoring the effects of therapy (Carlson, Amirahmadi, & Hernandez, 2012). Clinicians
use laboratory results to diagnose diseases and conditions, to make decisions about
hospital admission and discharge, and to determine the appropriate course of treatment
for patients. Accurate and timely laboratory results are important because a low
incidence of laboratory error has important public health and patient safety implications.
An inaccurate or incorrect test result may lead to additional cost and time consuming
follow-up testing (Snydman et al., 2012). Understanding the processes leading to
erroneous laboratory results in the preanalytical phase of testing should increase the
quality of care for patients and decrease preventable waste of valuable health care
resources.
Background of the Problem
Deaths associated with medical errors outpace the number of deaths occurring
from motor vehicle accident, breast cancer, or HIV/AIDS (Kalra et al., 2013). The
estimated cost of medical error is between $17.1 and $29 billion (Hammerling, 2012).
Researchers showed the defect rate in health care in the U.S. to be between 31% and 69%
(Hawkins, 2012). This research explored errors occurring in clinical medical laboratory,
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a sector of health care delivery. Compared to other healthcare sectors, medical
laboratories were a forerunner in the pursuit of quality (Lippi et al., 2013b).
Clinical medical laboratories performed approximately 6.8 billion tests and
generated $52 billion in revenue in 2007 (Carlson et al., 2012). This amount represents
only 2.3% of health care spending in the United States, but clinical medical laboratories
play a pivotal role in diagnosis and patient management. Clinicians based their diagnosis
decision on laboratory results 60-70% of the time (Abdollahi, Saffar, & Saffar, 2014).
Laboratories need to take mistakes seriously because clinicians depend on their results to
properly diagnose and treat patients (Plebani, 2014).
Clinical laboratory testing is comprised of three testing phases: preanalytical,
analytical, and post analytical (Hammerling, 2012; Hawkins, 2012). These phases are
also known as total testing phases (TTP), and dividing TTP into three different phases
allows medical laboratory managers to hone in on and address errors in each phase.
Examination of the successes of medical laboratory managers in reducing errors in the
preanalytical phase is the goal of this study. Seventy-five percent of TTP errors occur in
the preanalytical phase, and 26% can cause detrimental effects on patient care (Green,
2013). Given the magnitude of this issue, there was a need for this study.
Problem Statement
Reports indicated that up to 75% of laboratory errors occurred in preanalytical
phase of testing (Naz, Mumtaz, & Sadaruddin, 2012). The cost to investigate and correct
an error is nearly 25% of laboratory total expenses (Carlson et al., 2012). The general
business problem is that erroneous laboratory results lead to monetary loss and negative
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patient experience. The specific business problem is that some medical laboratory
managers lack strategies to mitigate errors in the preanalytical phase.
Purpose Statement
The purpose of this qualitative case study was to explore in depth how medical
laboratory managers reduce laboratory errors in the preanalytical phase. Participants for
this case study were medical laboratory managers in at least two medical laboratories in
southern California who reduced laboratory errors in the preanalytical phase. The
information yielded from the semistructured interviews provided management and health
care personnel with an avenue to reduce laboratory errors. Preventing the patient from
experiencing detrimental physical or emotional effects caused by laboratory errors will
contribute to a positive patient experience. This should elicit interest from leaders in
health care sectors as well as patients. Eliminating laboratory errors will improve patient
safety, reduce operational costs, and increase revenue.
Nature of the Study
The quality and quantity of data collection depends on the research method
chosen. Research methodologies included quantitative, qualitative and mixed-methods.
Quantitative research assumes that situations are measurable and observable through a
systematic process (Petty, Thomson, & Stew, 2012a). Quantitative data are numerical,
using statistical analysis while qualitative data consists of interview transcripts,
observations, drawings, or films that were not quantifiable.
Quantitative research is not apposite for this study because the data collection is
not numerical, nor does it use deductive reasoning to link theory and research (Zou,
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Sunindijo, & Dainty, 2014). My intent was not to test a hypothesis, but to understand
the perspectives of medical laboratory managers regarding their success in reducing
errors.
A mixed methods approach combines both qualitative and quantitative
methodologies to strengthen the breadth and depth of the subject under study (Wisdom,
Cavaleri, Onwuegbuzie, & Green, 2012). Mixed methods was not appropriate for this
study because the researcher was not interested in converging different methods to
explain a single phenomenon (Wisdom et al., 2012).
The qualitative research method was appropriate for this study because I sought to
understand the phenomena through the perspectives of the participants while identifying
the experience of physical and social realities (Erlingsson, & Brysiewicz, 2013). This
type of research produces a rich and complex description of people’s perceptions under
certain contextually specific situations. One difference between qualitative and
quantitative research is the type of data collected (Van Griensven, Moore, & Hall, 2014).
The qualitative research design depends on which perspective the researcher aims
to study. Three most commonly used qualitative research designs are case study,
phenomenology, and ethnography. Phenomenological design aims to understand the lived
experience of participants (Erlingsson & Brysiewicz, 2013), which was not the intent of
this study. Ethnography is a study of people in their everyday setting by examining the
shared patterns of behavior, beliefs, and languages within a cultural group (Petty,
Thomson, & Stew, 2012b). I had no intent to live alongside medical laboratory managers
to observe and interview the participants to develop an understanding of the cultural
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influences of the phenomenon under study. Case study researchers adopt this design with
the purpose of addressing an existing problem experienced by their professional practice
(Harland, 2014). A qualitative case study design was the most suitable design for this
study, as it allowed me to explore how medical laboratory managers reduce laboratory
errors in the preanalytical phase.
Research Question
The central research question guiding this study was: How do medical laboratory
managers reduce laboratory errors in the preanalytical phase?
Interview Questions
The interview questions were designed to capture the respondents’ practical
experience in reducing preanalytical errors. The following interview questions were
intended to answer the main research questions as well as the supporting research
questions.
1. How do you identify the areas that are the focus of preanalytical errors?
2. How do you diagnose the root cause of the problem? Do you use observations
and documentation to help diagnose the root cause?
3. How do you implement interventions that could potentially yield favorable
outcomes to minimize errors?
4. How do you reinforce the identified inventions to ensure effectiveness?
5. How important is quality in your organization?
6. What is your strategy to engage employees in developing a culture of quality?

6
7. How do you involve and empower all laboratory and other ancillary personnel in
cooperative efforts to achieve quality improvements in the preanalytical phase?
8. How can quality improve operational costs, patient care experience, and
competitive advantage?
9. How do you implement continuous improvement of employee’s capabilities and
work processes through training and education to reduce preanalytical errors?
10. What other preanalytical error reduction strategy you would like to share to help
medical laboratory managers address this issue?
Conceptual Framework
Total Quality Management (TQM) theory framed this qualitative study. The
framework of TQM concentrated on organizational survival (Zehir, Ertosun, Zehir, &
Müceldilli, 2012). Total quality management assisted in generating a better
understanding of medical laboratory managers’ experiences with preanalytical errors and
reveal their successes of minimizing these errors.
The origin of TQM is traceable to 1949 when the Union of Japanese Scientists
and Engineers (JUSE) formed a committee composed of scholars, engineers, and
government officials to address improving productivity and the quality of life in postwar
Japan (Powell, 1995). Total quality management framework consists of aspects from
Joseph Juran’s concept of the quality trilogy, Philip Crosby’s absolutes of quality
management, Armand Feigenbaum’s three steps of quality, and W. Deming’s 14 points
(Talib & Rahman, 2012). The combination of these important aspects created a
framework that promoted adding value to the product or service by setting and meeting
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goals with zero defects. Total quality management is accomplishable through top
management commitment, teamwork, and methods to measure process variations to
expose the root cause(s) of the problem.
Medical laboratory managers can use TQM to address laboratory errors through
trial and learning cycle. TQM could also help medical laboratory managers identify the
causes of preanalytical errors, diagnose the root cause of the problem, and implement
interventions that could potentially yield favorable outcomes. When implementing TQM
initiatives, the involvement of all stakeholders is important (Munechika, Sano, Jin, &
Kajihara, 2014) in the quest to strive for zero defects in patient care while meeting or
exceeding patient satisfaction (Nicolay et al., 2012).
Definition of Terms
Diagnostic error. A missed, wrong, or delayed diagnosis detected by some
subsequent definitive test or finding (Plebani, 2013).
Laboratory error. Defined as any defect occurring at any part of the total testing
phases (Lillo et al., 2012).
Medical error. The failure of a planned action to complete as intended, or the use
of a wrong plan to achieve an aim (Hawkins, 2012).
Quality control. The statistical tool laboratories use to monitor performance of
testing processes, detect potential errors, and correct discrepancies prior to reporting of
results (Lee, 2012).
Quality indicator. Defined as the objective measure that allows the users to assess
critical aspects of the testing processes (Plebani et al., 2014c).
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Assumptions, Limitations, and Delimitations
Assumptions
Assumptions made in this study were oversimplified ideas with a lack of
practitioner relevance (Böhme, Childerhouse, Deakins, & Towill, 2012). The first
assumption was that the participants are medical laboratory managers with adequate
experience in reduction of preanalytical errors. The second assumption was that the
experience acquired by these professionals will provide insightful information to this
study. A third assumption was that the invited participants will provide candid responses
to the semistructured interview questions. Honest replies were essential to preserve data
integrity and ensure the reliability and validity of this study. The final assumption was
that the participants will share strategies they used to minimize laboratory errors.
Limitations
Limitations are potential weaknesses in a research study (Kratochwill et al.,
2013). Identified limitations included geographical location, targeted population, and
trustworthiness of responses provided by the participants. The chosen geographical
location did not represent a comprehensive picture of the strategies used by medical
laboratory managers on a national and international laboratory industry. Restricting the
study to the state of California limits the generalizability of the findings resulting in
selection bias. An expanded sample population would provide the study with increased
validity and fewer data anomalies. Another limitation was the target population of the
study. The preanalytical phase of testing involved clinicians, couriers, phlebotomists,
laboratory assistants, and clinical laboratory scientists. However, this research limited

9
semistructured interviews to medical laboratory managers with abilities to minimize
preanalytical errors. This limitation did not provide an inclusive view of all professionals
involved in the preanalytical phase and eliminated a true random sampling of
participants. The integrity of the results is also a limitation to the study. Although the
assurance of confidentiality in the survey exists, the possibility of collecting
untrustworthy answers might occur.
Delimitations
Delimitations are the boundaries of the research study (Włodarczyk, 2014). The
scope of this qualitative study was to focus on the successes of medical laboratory
managers in minimizing preanalytical errors. Delimitations in this study included the
population and location. First, this study included medical laboratory managers with
laboratory experience and excludes all other laboratory personnel. Second, the
participant pool was inclusive to the state of California, which does not include
participants from other states or countries. Because of the identified delimitations, the
findings of this study did not assume the generalization of the successes of medical
laboratory managers with minimizing laboratory errors.
Significance of the Study
The number of estimated deaths associated with medical errors, 98,000, remains
largely unchanged since the release of the Institute of Medicine (IOM) report in 1999
(Ristić, Vasiljević, Rancić, & Ristić, 2014). The severity of this issue should promote all
health care entities to develop measures to minimize or prevent such occurrences. The
goal of this qualitative study was to address clinical laboratory errors. Errors caused by
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laboratories affect the healthcare system because up to 70% of clinical decisions depend
on laboratory results. Failure to provide accurate laboratory results affects the clinician’s
ability to diagnose and treat patients, resulting in adverse or detrimental events. Increased
operational costs could also result from these errors (Carlson et al., 2012). Such errors
are costly because of the additional resources required to investigate the issues with
unnecessary follow up tests. Academic literature revealed a gap in the research
pertaining to the strategies for reducing preanalytical errors, which prompted the need for
this study. With this research, I revealed strategies that medical laboratory managers
deployed to reduce errors in the preanalytical phase, and brought needed attention to the
importance of accurately reporting laboratory results so clinicians could provide proper
diagnoses and treatments.
The definition of a positive social change is an intentional process of creating
results for improving human and social conditions (Sharma & Good, 2013). This study
identified opportunities for laboratory managers to reduce errors; improve patient safety
and decrease operational costs. Over and above reducing the cost of medical errors,
saving lives is the focal point for health care delivery. Saving even one life will make a
positive social impact on both the patient and health care providers.
A Review of the Professional and Academic Literature
The primary source used to investigate preanalytical errors was a narrative
literature search. Using the existing data in the literature allowed the researcher to include
peer-reviewed journal articles that explained the outcomes from various researches. A
literature review allowed the researcher to extract evidence-based knowledge about the
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effects of preanalytical factors on laboratory results. This enabled the researcher to
summarize, explain, and interpret evidence pertaining to the preanalytical errors.
I obtained peer-reviewed journal articles from online portals, including Google
Scholar, Labmedicine.com, ASCP.org, and Walden University Library, along with
databases such as EBSCOhost, ProQuest, ABI/INFORM Global, ScienceDirect, and
ProQuest Dissertation and Theses. A review of the reference sections of pertinent peerreviewed journals also revealed additional information used in the literature review
section. This literature review included 99 articles with more than 85% peer-reviewed
journals published since 2012. These articles represented the most recent research of
biomedical preanalytical errors. Key words used to search for pertinent peer-reviewed
articles included: laboratory errors, diagnostic errors, quality assurance, total error,
medical errors, pre-analytical variables, total quality management, medical quality
management, quality management systems, and total quality management.
Application to the Applied Business Problem
The objective of this qualitative study with a case study design was to examine
the success of medical laboratory managers in reducing errors in the preanalytical phase.
Adverse events affect at least 1.3 million patients annually in the United States while
receiving medical care (Hannawa, 2014). This number surpasses the combined number
of injuries and deaths caused by motor and air crashes, suicides, falls, poisonings, and
drowning. Deaths resulting from medical errors are the eighth leading cause of death in
the United States. Given the magnitude of this issue, every institution in the health care
industry should explore ways to remedy the causes of these mistakes. Published studies
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illustrated that laboratory medicine attempted to address erroneous results, but despite
efforts at continuous improvement, the problem continues. As part of this effort,
laboratories need to develop and implement effective processes to minimize the
occurrence of errors because laboratory tests represent between 2.3% and 4% of health
care spending (Carlson et al., 2012; Warren, 2013). Compared to other healthcare
sectors, medical laboratories have been a forerunner in the pursuit of total quality (Lippi
et al., 2013b). The frequency of laboratory errors is between 0.012 to 0.6% (Agarwal et
al., 2012). Approximately 25% of laboratory errors affect patient care with 8% causing
temporary harm and 0.01% leading to death (Snydman et al., 2012). Even without the
adverse outcomes, laboratories need to take all laboratory mistakes seriously because
clinicians depend on laboratory results to properly diagnose and treat patients (Plebani,
2014).
Clinical laboratory medicine plays an integral role in patient care because medical
laboratory results influence 70% of clinical diagnoses (Atay et al., 2014). Clinical
decisions based on laboratory results include screening, early diagnosis, prognosis,
appropriate treatment and monitoring (Plebani et al., 2014a). Errors made by the
laboratory affect patient safety as well as costs to the healthcare system (Plebani,
Chiozza, & Sciacovelli, 2013a). More important than the additional millions of dollars in
wasted costs, these errors can cause adverse and potentially deadly effects for patients
(Favaloro, Funk, & Lippi, 2012). The laboratory industry attempted to mitigate these
errors by applying technological advances (Lippi, Plebani, & Favaloro, 2014).
Laboratories replaced manual processes with fully automated science to improve result
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accuracy and speed (Naz et al., 2012). This initative illustrated that the laboratory
industry was working toward achieving reliable results, but achieving quality would
require collaborative efforts from all healthcare entities. Laboratory testing is comprised
of three phases: preanalytical, analytical, and postanalytical (Hawkins, 2012). These
phases are also known as total testing phases.
TTP is a complex system that relies on procedures, equipment, technology and
human skills to provide clinicians with accurate and precise results for timely diagnosis
and treatment decision(s) (Agarwal et al., 2012). George D. Lundberg described TTP as
a brain-to-brain loop concept (Hawkins, 2012). The brain to-brain loop provides a
working paradigm to illustrate the physician to laboratory and the physician to patient
relationship (Plebani, 2012a). The brain-to-brain loop concept also provides laboratory
personnel with a systematic approach to identifying and classifying laboratory errors
(Hawkins, 2012). TTP consists of a nine step testing sequence including ordering,
collection, identification, transportation, separation (or preparation), analysis, reporting,
interpretation, and action specified by the brain-to-brain loop concept (Plebani, 2012a).
Breaking the total testing process into three distinct phases enables quality improvement
initiatives to target each phase individually (Hammerling, 2012). TTP begins with the
preanalytical step, where clinicians order the right test at the right time and the collection
of sample(s) is performed on the right patient (Tate, Johnson, Barth, & Panteghini, 2014).
The analytical phase includes sample analysis and reporting of the right results to the
clinician. TTP concludes in the postanalytical phase with the clinician’s interpretation of
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the results and a decision on the course of treatment based on test results (Hawkins,
2012).
Errors can occur in any phase of testing (Abdollahi et al., 2014). Errors occur at a
rate of 65.09% in the preanalytical phase, 11.68% in the analytical phase, and 23.2 % in
the postanalytical phase (Abdollahi et al., 2014). Errors in the analytical phase have
dramatically decreased in the past decade (Plebani et al., 2014b). The development and
implementation of quality indicators and quality specifications for effective management
of analytical procedures contributed to the decreased rate (Hammerling, 2012; Plebani et
al., 2014a). The standardization of analytical techniques, reagents, and instrumentation
showed improvements in the analytical phase (Plebani et al., 2013a). Postanalytical errors
also decreased dramatically with the implementation of interfacing analyzers and
laboratory information systems (Plebani et al., 2013b). Information technologies also
allowed quicker validation of results and notification of critical values. However,
preanalytical errors remained a challenge for all laboratories, as up to 70% of testing
errors occurred in this phase of testing (Abdollahi et al., 2014; Dolci & Panteghini, 2014).
Findings indicated that errors occurring during this phase of testing accounted for 46.0%
to 68.2% of all errors in TTP (Hammerling, 2012; Hawkins, 2012). Other data indicated
that 75% to 87% of preanalytical errors occurred in the preanalytical phase (Green, 2013;
Kemp, Bird, & Barth, 2012).
Many of the errors occurring in the pre-analytical phase are beyond the control of
the laboratory because many of the processes in this phase are manual, which are more
prone to human errors (Lippi et al., 2012). Preanalytical errors continued to flourish even
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though improvement initiatives, including automation and quality control, aimed to
minimize these errors (Guimarães, Wolfart, Brisolara & Dan, 2012; Simundic, Cornes,
Grankvist, Lippi, & Nybo, 2014). This phenomenon continued to exist because
laboratories did not have supervision of many of the processes occurring beyond the
laboratory walls (Simundic et al., 2014).
Substandard or inaccurate laboratory results from preanalytical errors prompted
the need for this research. Attempts to reduce error should commence with a review of
sources of these errors because errors in this earlier phase will cascade into the analytical
and postanalytical phases. Preanalytical variables defined by the International
Organization for Standardization (ISO) 15189:2012 include the clinician’s assessment of
a patient’s condition, ordering of tests, patient identification at time of sample collection,
collection of specimen, transportation of specimen, and specimen receipt at the laboratory
(Plebani, Sciacovelli, Aita, Padoan, & Chiozza, 2014c).
The cost of preanalytical error is between 0.23% and 1.2% of total hospital
operating costs (Green, 2013). This comes to approximately $1,199,122 annually in a
hospital with 650 beds. Preanalytical errors are a significant burden to hospital operating
costs because of repeat collection and retesting require additional resources (Green,
2013). Hospital and laboratory administrators should prevent or minimize the
occurrences of these errors to alleviate the financial constraints at their facilities and
decrease healthcare spending. Researchers studied preanalytical errors on a global scale
in an attempt to reduce these errors. Various researchers explored the high rate of errors
in this phase and suggested different solutions to minimize this problem (Gómez-Salgado
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et al., 2015). Several researchers concentrated on sample processes (Karcher & Lehman,
2014; Plebani, 2014; Yılmaz, Kıral, Boğdaycıoğlu, & Uysal, 2013) while others focused
on the effects of these preanalytical errors on patient safety (Green, 2013; Naz et al.,
2012; Waheed et al., 2013). The exploration of diverse aspects of preanalytical errors
was evident in the literature, but a study to explore the perspective of medical laboratory
managers who successfully reduced laboratory errors in the preanalytical phase was not.
This study aims to explore the perspective of medical laboratory managers to close the
existing gap.
A well developed, implemented, and monitored quality management system
(QMS) could aid clinical laboratories in producing accurate and reliable laboratory test
results (Funk, Lippi, & Favaloro, 2012). Included in this QMS are quality standards
meant to address sample processing, transportation, and storage of specimens. QMS
should also include defined procedures, training, and competencies. Staff must adhere to
these standards because any deviations could lead to undesirable outcomes in patient
care. The most effective strategy to minimize laboratory errors was to develop a
comprehensive Total Quality Management system (Hammerling, 2012). TQM could
provide laboratory managers with tools to dissect preanalytical processes to analyze the
root cause of errors. The revelation of the root cause of errors could lead to the
development and implementation of solutions to mitigate this issue.
Application to Conceptual Framework
Leading practitioners view TQM as a strategic tool to compete in the current
competitive business market. TQM concentrates on continuous improvement of products
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or processes to meet or exceed customer expectations (Talib & Rahman, 2012). This
framework demands that all stakeholders are responsible for the quality of the product
they produced or used (Nicolay et al., 2012). Stakeholders include management,
workforce, suppliers, and customers. Leaders can adopt TQM to monitor process
management, customer feedback, leadership commitment, strategic planning, supplier
quality management, and employee engagement. TQM, as a quality management
practice, aims to improve quality of products and services, performance, and attain higher
market share (Lee, 2012).
Quality leaders including Edwards Deming, Joseph Duran, Armand Feigenbaum,
and Kaoru Ishikawa provided the foundation for TQM. The evolution of TQM traced
back to post World War II when JUSE formed a committee to improve productivity and
quality of life in Japan (Powell, 1995). American companies adopted TQM as a strategic
tool to compete with Japanese companies in the 1980’s. Initially, the implementation of
TQM was in the manufacturing sectors, but as TQM gained popularity, the service
industries including healthcare industry, banking sector, higher education institutions,
real estate, and hotels and tourism sectors adopted TQM as a strategic move to appease
customers while achieving quality metrics (Talib, 2013).
The health care industry has experienced quality issues on a global scale in the
last few decades (Serteser, Coskun, Inal, & Unsal, 2012). The IOM report released by the
United States in 1999 indicated that the quality of health care delivery is poor with as
many as 98,000 preventable deaths occurring each year (Green, 2013). Laboratory
medicine (a subset of health care delivery) is the forerunner of quality improvement in
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health care, but continues to struggle with quality issues affecting their services
(Hammerling, 2012). Diagnosticians rely on laboratory results to diagnose, evaluate, and
management patients’ conditions (Snydman et al., 2012). Erroneous results could cause
emotional or adverse distress as well as increased cost. To improve quality, and alleviate
costs, many health care organizations implemented TQM as a methodological strategy to
achieve quality and increase firm value through process improvement (Lee, 2012). TQM
has sustainable competitive advantage if implemented correctly (Talib, 2013).
TQM is relevant to this study because of its potential to improve laboratory
performance. The highest standard of quality in the preanalytical phase of testing is
achievable in laboratory medicine through the development and implementation of a
TQM system (Hammerling, 2012). TQM is applicable to this study through standards
defined by laboratory accreditation bodies such as the International Organization
Standard 15189 (Talib, 2013). ISO 15189 is an internationally recognized standard that
outlines specific requirements for medical laboratories to demonstrate their competence
in delivering reliable laboratory services (Serteser et al., 2012).
Commitment is pledged to meet or exceed customer satisfaction by achieving
defined quality and services. Customer orientation is the central focus of TQM by
meeting or exceeding customer satisfaction. Doctors, nurses, and all ancillary entities are
laboratory customers involved with the care of the patient. TQM requires that
organizations know what customers need and how to achieve customer satisfaction. This
aspect of TQM requires the organization to produce a quality product or service.
ISO 15189 required that organizations meet this condition through four
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requirements: organization and management, review of contract, external services and
supplies, and resolution of complaints (Allen, 2013). Organization and management
require the laboratory to outline the needs and expectations of customers, as well as the
role and responsibilities of each staff member. Review of contract requires laboratories
to review the agreement of defined needs and expectations of customers periodically.
External services and supplies requires the definition of procedures for handling
inventory and storage to ensure that adequate supplies are available to meet the demand
of the customers. Resolution of complaints defines the need to document, investigate,
and provide corrective action to meet customer satisfaction. The support of senior
management is essential for the success of TQM implementation. To encourage
participation, top management should empower employees to suggest process
improvement ideas and involve staff in the development and implementation of these
processes. Without this element, the chance of implementing TQM successfully will
decrease.
Involvement is including all team members from top to bottom to achieve a
common goal (Talib, 2013). ISO 15189 requirements that address involvement include
quality management systems, advisory services, and management review. QMS includes
a laboratory’s quality policy and quality objectives, as well as all other policies,
processes, and procedures involved with laboratory operations. QMS dictates
management involvement in communicating laboratory quality policy and quality
objectives to all staff. Advisory services ensure that each staff member has mechanisms
to provide input regarding services offered by the laboratory. Management review
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requires regular assessment by all stakeholders to ensure the continual suitability and
effectiveness of the QMS. This assessment should include discussion of the status of
corrective and preventive actions, internal and external audit reports, feedback from
customers, quality indicators, and any necessary changes needed to improve the QMS.
Continuous improvement is the process of exploring for defects and correcting them
(Talib, 2013). ISO 15189 requirements of identifications and control of conformities,
corrective action, preventive action, quality and technical records, internal audits, and
technical requirements meet TQM aspect of continuous improvement.
Continuous improvement outlined by ISO 15189 specified that laboratories must
review their procedures regularly to identify potential sources of nonconformities and
opportunities for improvement (Allen 2013). The expectation is for laboratories to
expose root cause, develop, and implement corrective and preventive actions to address
these conformities upon identification. When nonconformance occurred, root cause
analysis was essential to expose possible errors and identify weaknesses in the system
that allowed these failures to occur (Reid & Smyth-Renshaw, 2012). Laboratories should
also implement preventive and corrective actions to avoid issues from occurring or
recurring. Applying the TQM approach to detect preanalytical error requires the
involvement of all employees in the mapping of all processes, development and
implementation of all processes, and to define metrics for each process (Olofsson,
Banker, & Sjoblom, 2013).
Laboratories need to perform internal audits at set intervals to ensure that all
processes conform to QMS requirements. Quality and technical records need to be

21
available upon request and recorded according to regulations. Implementation of
technical requirements, including personnel, preanalytical, analytical, and postanalytical
procedures, is essential to ensure quality. Personnel procedures must outline adequate
staffing as well as hiring, training, competency assessment, performance evaluations, and
continuing education. Preanalytical, analytical, and postanalytical procedures should
include all processes from test ordering to the release of results. These procedures must
define each step involved and be available to staff. The procedures should be complete
and written in a standard style so all employees can understand and follow them.
Customer satisfaction is only achievable through continuous improvement and
commitment from all stakeholders.
The components presented above are an integration of findings from a literature
review of TQM as a quality improvement theory. Different aspects of TQM provide a
conceptual framework for understanding and studying quality improvement in laboratory
medicine. Components of TQM offer laboratory leaders a methodological approach to
quality improvements. Laboratories should develop and implement an effective TQM
system to reduce process variations, eliminate waste, minimize errors, and improve cost
of quality. This framework can help laboratories gather data, analyze data, and diagnose
the source of errors. TQM is applicable to this study because it promotes a quality
culture by involving all employees in the detection, prevention, and management of
errors. Most importantly, if implemented effectively, TQM has the potential to improve
patients’ experiences with laboratory testing. To summarize, TQM has the potential to
ensure improvement of clinical operation and financial performance while increasing job
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satisfaction among employees.
Relevancy of the Literature
The purpose of this case study is to explore medical laboratory managers’ abilities to
minimize laboratory errors. A thorough review of existing literature revealed three
general categories pertaining to preanalytical errors: causes and types of errors, the effect
of quality assessments, and the application of technological advancements and
harmonization to minimize errors. This review of the literature presents findings from
each area of focus, along with a discussion of their significance. This literature review
groups the journals into three categories according to content, as noted above.
Preanalytical variables. Statland and Winkel introduced the term preanalytical
factors in 1977 to describe variables that influenced laboratory results before the testing
of the sample (Guder, 2014). This term evolved to preexamination procedures and then to
preanalytical phase. Preanalytical phase is a complex and dynamic process and involves
many health care professionals from different disciplines (Gómez-Salgado et al., 2014;
Lippi et al., 2013b). The preanalytical phase includes sample collection, sample
handling, and sample transportation (Yılmaz et al., 2013). Activities in this phase
include, but are not limited to test request, patient and specimen identification, blood
collection, centrifugation, sorting and deliverance of specimens to the laboratory (Naz et
al., 2012). Errors in this phase are often random and undetectable by normal quality
control methods. This phase is more vulnerable to errors because some activities occur
outside the laboratory.
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Laboratories need to examine the different causes of preanalytical errors because
any trivial error could potentially harm the patient. Detectable preanalytical errors can
require additional resources to recollect the specimen, add processing time, and delay of
result reporting (Green, 2013). There have been situations where the error adversely
affected patient diagnosis or treatment because the error remained unidentified until after
the physician received the report. One report indicated that human mistakes contributed
to the majority of preventable preanalytical errors (Rana, 2012). Another report
suggested that system failure is the reason for errors and not just human fallibility (Kalra
et al., 2013). Targeting individuals as problems is not an effective solution. To prevent
mistakes, health care professionals need to examine the layers of complexity to expose
factors causing laboratory errors. The human role in the collection of samples makes
complete elimination of these errors an unrealistic goal. Implementation of preventive
measures to minimize these errors in sample collection, sample collection techniques,
collection of samples into proper containers, and proper storage and transportation is
achievable through collaborative efforts.
A majority of preanalytical errors take place before the sample arrived at the
laboratory (Green, 2013). Key preanalytical errors identified by various researchers are
misidentification, incorrect samples, clotted samples, inadequate samples, hemolysis,
inappropriate temperature, and time during specimen transportation. One study showed
that 1% of preanalytical errors occurred in all samples, with the misidentification of
samples noted as the main culprit (Upreti, Upreti, Bansal, Jeelani, & Bharat, 2013).
Another study demonstrated that hemolysis is the major cause of preanalytical errors
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resulting in specimen rejection (Giménez-Marín, Rivas-Ruiz, Pérez-Hidalgo, & MolinaMendoza, 2014). Yet, another study showed that clotted samples are the leading
contributor to preanalytical errors (Bhat, Tiwari, Chavan, & Kelka, 2012). Preanalytical
errors occur more frequently in inpatients than outpatients (Plebani, 2014). Reasons
attributed to this trend are (1) insufficient standard operating procedure for test request,
sample, collection, handling, and transportation; and (2) inpatients are harder to draw
because of age and disease issues.
Body of evidences in the literature revealed that many researchers aimed to
uncover causes of preanalytical errors and corrective action suggestions for these issues,
but there were a scant number of studies performed seeking the perspective of health care
professionals. Two studies aimed to understand the perspective of professionals involved
with the preanalytical process, and their hands on experience in this area, which might
identify the types and causes of mistakes (Gómez-Salgado et al., 2014; Gómez-Salgado et
al., 2015). The first study revealed three areas that could produce preanalytical variables:
inadequate training, increased workload, and deficient work organization (GómezSalgado et al., 2014). Results from the second study indicated that workload increase is
the main reason for variability in the preanalytical phase while commenting that
organizational capability and teamwork could overcome these issues (Gómez-Salgado et
al., 2015).
Test request. Heath care spending outpaced the growth rate of the United States
gross domestic product (Warren, 2013). Evidence revealed that physicians directly
influenced these costs. Test requests are under the control of the attending physicians
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upon the completion of patient examination (Aarsand & Sandberg, 2014). Depending on
the outcome of the examination, the physician diagnoses the condition and orders the
proper analyses to complement the diagnosis. Studies indicated that clinicians are over
ordering tests to diagnose a condition (Naz et al., 2012). There is a lack of correlation
between the number of tests ordered per patient and clinical outcomes. Factors
contributing to overuse of diagnostic tests include physicians’ practice of defensive
medicine, patient expectations, lack of understanding of the limitations of tests ordered,
reordering tests because of an inability to retrieve previous results, and economic
incentives (Feldman et al., 2013). Test requests vary depending on clinicians or the
prevalence of disease in the area (Aarsand & Sandberg, 2014). Probable causes of
inconsistent test requests include insufficient knowledge, inadequate training, and
inability of the laboratory to perform the test. The misuse of laboratory services is under
scrutiny worldwide because this practice affects the total healthcare cost and the
increased risk of medical error and injury. Excessive test ordering lead to diagnostic
errors (Epner, Gans, & Graber, 2013). For example, if a physician orders an
inappropriate test and the analysis yields a false positive result, the clinician could
inappropriately treat a patient based on this result. The clinician might order additional
tests, or unnecessary procedures, that harm the patient. Other sources of errors caused by
ordering physicians include incomplete or incorrect information on the test request form
and underutilization of appropriate tests (Epner et al., 2013; Naz et al., 2012).
Incomplete or incorrect information on the test request form can lead to delay of results
and the possibility of misidentification of patients. Underutilization of appropriate tests
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can lead to a missed or delayed diagnosis. These affect the quality of care that patients
receive. The estimation of the inappropriate use of laboratory tests varies from 5% to
95%, depending on the tests ordered.
Data suggested the inconsistency of test ordering is due in part to the complexity
of laboratory tests and inadequate training at the medical schools (Plebani, 2012a). The
expansion of test menus makes ordering appropriate tests more difficult. Experts
performed studies assessing strategies that could improve costs and efficiency. One
study asked clinicians to substitute a request for an individual test with a clinical question
or diagnostic suspicion (Laposata & Dighe, 2007). Based on the clinical question, the
clinicians ordered a preliminary panel of tests with the intent to diagnose the disease
conclusively. If a diagnosis is inconclusive, the clinicians could order further tests
through diagnostic algorithms and reflex testing. The conclusion was that this strategy
could reduce cost while providing accurate and faster diagnosis for the patients.
Another strategy involved the laboratory setting standards according to clinical
conditions through predetermined test profiles or problems (Aarsand & Sandberg, 2014).
When a patient presents a clinical manifestation of a myocardial infarction, and the
system automatically orders a specific panel of tests to diagnose this condition, is an
example of predetermined test profiling. An example of a problem-based test profile is
when a sample yields a positive result and the order for subsequent tests automatically
occurs. The laboratory can set up parameters to prevent repetitive testing. Failures to
order tests and completing test request forms appropriately can lead to diagnostic errors.
Collective efforts by laboratory and clinical staff to address this issue might reduce these
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errors. The expertise that each group brings to the issue will improve patient safety by
properly diagnosing the patient’s condition through appropriate tests ordered.
Specimen collection. Proper specimen collection is the first step to ensure the
quality of laboratory test results. Blood sample collection and handling are two important
preanalytical activities in the TTP (Lippi et al., 2012). Addressing preanalytical variables
in specimen collection, such as qualifications of blood collector, proper technique, and
training and adherence to guidelines could increase the reliability of the test results. One
issue that might arise during sample collection includes the lack of experience by
collectors in handling the pressures of a busy clinic or multiple collection requirements
(Lippi et al., 2013b). Another issue is the application of improper technique when
extracting blood from patients (i.e., difficult blood draws or those derived from central
lines) that could lead to partially clotted or hemolyzed samples. Inadequate training and
adherence to policies were also sources of error in blood collection.
Phlebotomy. Blood collection, or phlebotomy, is the most common medical
procedure performed on patients, and it involves complex procedures that require the
operator to possess knowledge and manual skills. Phlebotomy is a manual procedure for
which many experts cannot foresee the automation capability of this process (Waheed,
Ansari, & Zaheer, 2013). Proper sample collection plays a pivotal role in avoiding
preanalytical errors because errors have a tendency to occur in any situation where the
processes are manual (Lima Oliveira et al., 2012).
Phlebotomists traditionally are the main operators for blood collection. However,
other healthcare professionals also perform this duty (Favaloro et al., 2012). Inconsistent
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training for healthcare professionals poses a problem with the quality of the blood drawn.
Correct blood collection techniques and the skills of the trained operator ensure the
collection of an optimal sample (Lippi at al., 2012).
Comparison studies assessing the occurrence of preanalytical errors between
outpatient and inpatient units illustrated that preanalytical errors were more common in
the inpatient units (Davidson, 2014; Upreti et al., 2013). The primary reason for this is
that nurses and paramedical staff collect blood in inpatient units while phlebotomists
collect blood in the outpatient units. The cause of the frequent occurrence of
preanalytical errors in these inpatient units is the inconsistent training provided to the
nurses and paramedical staff. Many of these professionals are not aware of the proper
technique for collecting blood. Phlebotomists’ main duties are to collect blood, and these
individuals have certifications and training provided through educational policies (Lippi
et al., 2012). Through proper techniques, phlebotomists are more productive in drawing
blood safely and successfully. Phlebotomists must perform their duties in a skillful, safe,
and reliable manner to create an atmosphere of trust and confidence. Important
characteristics that phlebotomists should have include a proper manner, and the ability to
communicate and interact with patients effectively (Waheed et al., 2013). Increased
preanalytical errors occur when blood collection does not involve a phlebotomist at a
primary health care center and in hospital wards (Simundic et al., 2013).
Preanalytical errors such as hemolysis and Ethylenediaminetetraacetic Acid
(EDTA) contamination were lower when phlebotomists performed blood collection
(Davidson, 2014). A study conducted at two hospitals in Scotland discovered that
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hemolysis and EDTA contamination occurrences were higher in inpatient than in
outpatients (Davidson, 2014). Another study compared misidentification, inappropriate
collection vials, clotted samples, inadequate samples, diluted samples, and hemolyzed
samples between inpatient and outpatient units. That study found that 1.34 % of
preanalytical errors occurred in the inpatient units while only 0.69% occurred in the
outpatient units. Common errors were misidentification or mislabeling of vials.
Inadequate training provided to the nurses and other health care professional was the
main reason this phenomenon existed (Davidson, 2014). As a result, proper phlebotomy
practice has the potential to prevent and minimize preanalytical errors. Controlling
phlebotomy is difficult, but if this area goes unrecognized, the quality of a sample test
will be poor.
Improper techniques. Phlebotomy is the process where laboratory professionals
perform venipuncture, capillary, or arterial puncture on patients (Waheed et al., 2013).
Venipuncture is the collection of blood from the venous system. Capillary puncture is
the collection of blood through the capillary from patients who are hard to draw, to
minimize injury. Arterial puncture is the collection of blood from the arteries.
Neglecting the importance of proper techniques used in blood collection could lead to the
compromise of test results affecting patient safety.
Improper techniques, such as site preparation, prolonged application of
tourniquet, inadequate collection, and wrong order of blood draws, are errors that could
lead to falsified results (Waheed et al., 2013). Prolonged application of the tourniquet
and excessive clenching of the fist affects the concentration of several analytes by
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creating venous stasis, and changes the local pH balance (Lima-Oliveira et al., 2012).
Venous stasis and excessive rubbing could introduce microorganisms to the sample, and
simulate vascular dysfunction by introducing endothelial cells in the samples. Proper
techniques ensure the quality of collected specimens, and include appropriate mixing of
blood tubes and collection of sample in proper container (Lippi et al., 2012). Appropriate
mixing of blood tubes creates a homogeneous solution of blood and additive. Using the
appropriate container for specific tests minimizes erroneous results.
A study that evaluated the performance of 30 phlebotomists identified the main
sources of error during blood collection (Lima-Oliveira et al., 2012). Techniques
observed were tourniquet time, request for fist clenching, skin cleaning, order of tubes
draw, and mixing of blood after collection. Twenty-eight of the phlebotomists observed
removed the tourniquet within the 60 seconds recommended by the Clinical and
Laboratory Standards Institute (CLSI). The study found that 83% of venipuncture
procedures used excessive clenching of the fist and 85% applied significant rubbing at
the venipuncture site. Many of these phlebotomists did not see the importance of
appropriate collection order of blood, and 80% did not follow the recommended
sequence. Many phlebotomists considered this practice as unnecessary and did not
understand that adequate mixing of blood in tubes with anticoagulants or additives will
ensure that those ingredients are working.
Applying proper technique during blood collection can help prevent hemolysis
and may minimize interferences that can lead to erroneous results (Prajapati, Prajapati, &
Vora, 2014). Hemolysis is the most common preanalytical interference and the main
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reason for sample rejection in laboratories (Simundic &Lippi, 2012). The majority of
hemolyzed venous blood specimens were the result of poor collection and handling of
samples (Bölenius et al., 2013). Causative factors of hemolysis included injury caused by
needles and application of the needle to the skin before the evaporation of alcohol from
the skin. Applying proper phlebotomy techniques could minimize hemolysis (Lippi et
al., 2013b).
Insufficient sample volume is problematic when the operator does not fill the
tubes with the correct amount. Poor quality and inadequate volume of insufficient
specimen contribute to over 60% of preanalytical errors (Rana, 2012). Erroneous results
associated with insufficient sample volume can result in elevated analytes because of
incorrect additives and blood ratios (Green, 2013). For example, if the collector only
collects 3 mL of blood in a 5 mL heparin tube, the high heparin concentration might be
erroneously elevated and could interfere with some analytes. Insufficient volume requires
a redraw of specimen if the amount submitted cannot complete all tests ordered. This
delays the receipt of test results and prolongs the patient’s stay in the hospital, which
results in added operational costs to the hospital. Possible causes of insufficient volume
include the lack of knowledge by the phlebotomist and difficult sampling (Naz et al.,
2012).
The order of blood draw is another technique that phlebotomists must follow to
avoid errors. Collection of multiple tubes of blood is a common practice at many health
care facilities. Each collection tube contains a specific additive that is suitable for
particular types of tests (Lippi et al., 2012). The color of the rubber stopper on the tube
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differentiates the addictive in the tube. To prevent additive carryover, CLSI guidelines
recommended the order of the draw as: follow blood culture bottle or tube, coagulation
tubes, nonadditive tube, clot activators, sodium heparin, lithium heparin,
ethylenediaminetetraacetic acid, acid citrate dextrose, and oxalate or fluoride tubes.
Collection of blood tubes out of order often produces inaccurate results, even with the
most advanced laboratory instrument (Waheed et al., 2013). The modification of this
sequence has the potential to introduce contamination into primary collection tubes
through carrying over additives (Lima-Oliveira et al., 2012). Blood collection must
follow specific orders to prevent cross contamination that could affect the analytical
results. The order of blood draw affects the quality of sample and has the potential to
cause erroneous results because of contamination from the previous blood collection tube
(Rana, 2012). Transferring blood from one tube to another should not occur because this
poses safety and technical issues. Proper blood collection tubes could prevent various
preanalytical errors leading the adverse effect of laboratory errors on patient safety (Lippi
et al., 2013b).
Wrong order of draw affects the results of tests and the following study illustrated
this effect (Lima-Oliveira et al., 2013b). The study set out to prove that the incorrect
order of blood draw could cause erroneous hyperkalemia and hypocalcemia. That case
study collected specimens from a 45 year old male patient without any clinical
complaints. The tube draw order was clot activator and gel separator (serum vacuum
tube), K3EDTA, and lithium heparin. Potassium results were 4.8 mmol/mL and 8.5
mmol/mL for the serum vacuum tube and lithium heparin, respectively. Sodium results
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were 2.36 mmol/mL for the serum vacuum tube and 1.48 mmol/L for the lithium heparin.
Subsequent extraction of blood, excluding the K3EDTA tube, produced results of 4.7 and
4.5 mmol/mL for potassium and 2.37 and 2.38 mmol/L for the sodium. This proved that
when K3EDTA drawn before lithium heparin affects the results of potassium and calcium
in the blood, causing hyperkalemia and hypocalcemia. The spurious results required
additional tests to rule out chronic kidney disease. This delay caused additional anxiety
to the patient and increased costs to the health care system.
Training and education. The occurrence of preanalytical errors is more prevalent
because this phase of testing involves professionals from different disciplines (Romero,
Cobos, Gómez, & Muñoz, 2012). Improving blood specimen quality is the goal of
reducing error in the preanalytical phase (Green, 2013). Insufficient training for improper
puncture of veins or arteries can produce serious patient harm (Simundic et al., 2013).
Blood collection is an important aspect of laboratory testing, but the existence of
international guidelines on phlebotomy is scant (Lima-Oliveira et al., 2012). One set of
guidelines is from the CLSI and another is from the World Health Organization.
Phlebotomy processes vary tremendously across countries because of poor enforcement
by the accrediting bodies (Simundic et al., 2013). Lack of training and adherence to
guidelines are cited by multiple sources as the cause of blood collection errors.
Several studies indicated that adherence to predefined phlebotomy guidelines is
poor (Green, 2013; Lima-Oliveira et al., 2012; Simundic et al., 2013). Reasons for low
compliance to practical procedures are lack of theoretical knowledge, unfamiliarity with
content of guidelines, poor attitudes toward the guidelines, and work overload (Green,
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2013). Guidelines provided by CLSI and WHO are cumbersome and are not suitable for
daily practice (Lima-Oliveira et al., 2012). Amending staff behavior toward established
guidelines is proven difficult task (Bölenius et al., 2013). Lack of adherence to the
guidelines occurs because of the complexity of the procedure, skepticism by the
employees, and implementation of guidelines. The guidelines with the most success are
easy to understand and applicable to the practice. Other impediments include lack of
support from upper management, insufficient staff, and the roll out strategy of the
implementation. Standardizing blood collection could be most beneficial for improving
the quality of blood specimens (Green 2013). Mishandling or the lack of compliance to
blood collection procedures is a serious issue that needs the collective involvement of
international organizations, national societies, and professionals to resolve (Waheed et
al., 2013). The international laboratory community needs to modify and adopt guidelines
that would be appropriate for the phlebotomists to follow.
Upreti et al. (2013) noted that education and training and established quality
procedures might decrease preanalytical errors. Better training in blood collection and
standardization of professional phlebotomists will reduce the danger of misinterpretation
of results and decrease laboratory operational costs (Davidson, 2014). Proper training,
with emphasis on the sources of errors, should improve the quality of preanalytical errors
(Lima-Oliveira et al., 2012). The most favorable outcome is for robust training and
performance monitoring of phlebotomists through continuing education (Simundic &
Lippi, 2012). Education and training of staff could ensure that specimen collection and
handling do not create errors (Waheed et al., 2013). Equally important is for trained
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phlebotomists to follow their laboratory’s standard operating procedures and policies to
avoid errors.
Surprise findings in two studies signified that interventional education increased
the number of preanalytical errors (Bölenius et al., 2013; Romero et al., 2012). The
findings contradict the beliefs of many scholars that training and education is a
mechanism to reduce blood collection errors. To prove the benefits of updated training,
the first study collected data from 29 primary care offices and hypothesized that updated
training could reduce preanalytical error from the primary care office (Romero et al.,
2012). Aggregation of data includes pre and post implementation of educational
sessions. Preanalytical errors increased after implementation of education intervention,
to the dismay of the authors. Most notable was the increased number of hemolyzed
samples. The researchers cited that hemolysis could also occur in specimen handling and
transportation. A similar study evaluated whether a correlation existed between
educational intervention and hemolyzed samples (Bölenius et al., 2013). Results showed
that a slight observation of increased hemolyzed specimens after the education
intervention. The cause of this phenomenon was unknown, but the authors noted that
hemolyzed specimens increased in the rural hospitals and decreased in urban hospitals. A
possible explanation for this outcome is that urban hospitals adhered to guidelines;
whereas, compliance at the rural hospital was scant. The complexity of blood collection
procedure and various health care professional involvements in this process created
errors. Researchers from various continents searched for solutions through various
approaches (Romero et al., 2012). The recurring themes from these strategies were
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training and adherence to guidelines. To mitigate blood collection errors, the
international community must develop and foster the adoption of standardized guideline.
Conclusions from these two studies noted that compliance to guidelines is more effective
than training.
Specimen handling. Improper specimen handling can lead to rejections of
samples. Sample rejection may occur if the samples are unsuitable for laboratory testing
(Karcher & Lehman, 2014). Reasons for rejections included mislabeling, inadequate
labeling, defects in the quality and quantity of samples received, and centrifugation.
Significant consequences for patients and clinical management may result because of
specimen rejection. The result of rejected samples was the recollection of blood and
exposure of patients to discomfort because of repeated phlebotomy. The cascading effect
was the delay of results and clinical diagnoses or treatments.
Misidentification. Misidentification can occur with the specimen or patient
(Salinas et al., 2013). Incorrectly labeled or unlabeled specimen tubes were specimen
misidentification errors that could occur during phlebotomy. Patient misidentification
was notorious as a recurring error in the TTP (Aarsand & Sandberg, 2014). Two reasons
leading to errors resulting in patient misidentification were performance of phlebotomy
on the wrong patient and registering incorrect demographic information into the
laboratory information system (LIS). Misidentification errors during sample collection
could potentially delay diagnosis, cost additional resources to redraw and retest, and
result in inappropriate medical treatment (Green, 2013). Patient misidentification is
inexcusable and preventable, and eradication of this issue is fundamental to safety
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improvement (Rana, 20120; Salinas et al., 2013). Proper patient identification in
sampling collection is important because errors could have mild to life threatening
consequences (Naz et al., 2012). Mismatching patient identity could lead to an acute
hemolytic reaction in a blood transfusion, resulting in fatality. The safest approach to
correct a misidentified sample is to recollect and retest the patient while performing an
investigation of the event (Favaloro et al., 2012).
Overemphasizing the importance of proper identification is essential in curbing
this issue (Favaloro et al., 2012). The Joint Commission (TJC) reiterated the importance
of proper identification and supported this effort for the last decade (Lippi et al., 2012).
To avoid misidentification in an outpatient setting, patients need to provide identification
and to identify themselves. TJC endorsed the use of two patient identifiers, and to only
label tubes when the phlebotomist is present during collection of blood samples and other
specimens for clinical testing (Lippi et al., 2012). Avoidance of labeling after collection
is necessary because this process is vulnerable to errors.
Hospitals implemented bar coding, radiofrequency, and wristbands to promote
positive patient identification (Favaloro et al., 2012; Lippi et al., 2012; Naz et al., 2012).
Other positive identifiers include printing labels for tubes, matching patient identification
with the patient’s full name, date of birth or medical record number, and identification of
collection date and time (Naz et al., 2012). A working group under the ISO Technical
Committee 212 is preparing a guidance document on quality practice for the collection
and submission of primary samples for medical laboratory examination (Aarsand &
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Sandberg, 2014). Ensuring compliance with standardized, correct patient identification
procedure is important (Naz et al., 2012).
Unacceptable specimen qualities. The highest quality of blood received in the
laboratory will yield the most reliable results. Studies, practitioners, and researchers
stressed that hemolyzed samples, clotted samples could lead to erroneous results through
the introduction of interference and activation of factors and platelets. Hemolyzed and
clotted samples were the main causes of sample rejection.
A major factor affecting preanalytical errors producing unreliable laboratory test
results is hemolysis (Dolci & Panteghini, 2014). Hemolysis in samples was the most
prevalent among all preanalytical problems (Lippi, Avanzini, & Cervellin, 2013a).
Hemolysis is the cause of approximately 70% of unsuitable specimens arriving to the
laboratory (Green, 2013). Rejected samples caused by hemolysis outpaced other causes
(insufficient, incorrect, and clotted samples) by five times (Heyer et al., 2012). Incorrect
sampling procedures, mishandling of samples, or sample transportation was responsible
for over 95% of hemolyzed samples (Naz et al., 2012). Hemolysis is the destruction of
red blood cells that releases the hemoglobin and intracellular contents from the cells to
surrounding plasma. A pink or red tint of the plasma or serum is indicative of hemolysis
(Dolci & Panteghini, 2014). The color in the sample increases the spectrometric
absorbance and can lead to high background absorbance reading that can yield inaccurate
result. Through a variety of biological and analytical mechanisms, hemolysis can also
produce interferences resulting in erroneous laboratory results. A slight amount of
hemolysis can falsely elevate certain analytes, including but not limited to, lactate
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dehydrogenase, creatinine kinase, potassium, aspartate amniotransferase, and alanine
aminotransferase (Green, 2013). The false elevation of these levels may not provide the
clinician with an accurate picture of the patient’s condition for proper diagnosis.
Hemolysis might result from a problematic collection or the result of poor
handling of blood post collection (Favaloro et al., 2012). Hemolyzed samples are a
concern for coagulation tests because the breakdown of erythrocytes during blood
collection could inhibit or activate both primary and secondary hemostasis in vitro
(Plebani, 2012a). A problematic collection is forcing of blood through a large-bore
needle causing red blood cells to lyse (Favaloro et al., 2012). Poor handling of blood
post collection is vigorous mixing of sample causing red cells to rupture. Accurate
mixing of blood after collection is necessary for the anticoagulant or clot activator to
work effectively (Lima-Oliveira et al., 2013a). Avoidance of vigorous shaking of tubes
after collection, traumatic venipuncture, and collection of insufficient volume to prevent
hemolysis in samples is key (Rana, 2012). Although there was existing guideline to aid
phlebotomists through this process, the lack of uniformity encouraged each phlebotomist
to perform the steps differently. Researchers postulated that vigorous mixing resulted in
hemolytic samples that led to sample rejection or erroneous results. A study evaluating
the strength (gentle versus vigorous) of mixing and its effect on laboratory results showed
that vigorous or gentle mixing did not produce variability with laboratory results (LimaOliveira et al., 2013a). To conclude, the authors explained that the findings of this study
did not meet the paradigm that suggested incorrect mixing of blood promoted laboratory
variability.

40
The existing problem with hemolyzed samples from the emergency department
(ED) is delayed treatment because of recollection of samples (Heyer et al., 2012).
Recollection of samples also subjected the patient to additional discomfort and added to
the health care cost. Hospital ED has a hemolysis rate of up to 30%, which was highest
among all hospital departments (Heyer et al., 2012; Lippi et al., 2013a). The causes for
this elevated rate were lack of standard practices for blood collection in ED, inadequate
training and competency, and insufficient oversight from the laboratory. Systematic
review revealed improvement of certain techniques could reduce the hemolysis rate in
ED (Heyer et al., 2012). Technique that prevented hemolytic activities were use a
straight needle for phlebotomy, avoiding collecting blood from an intravenous (IV) line,
using low vacuum tubes, and using less than or equal to 21 gauge syringes. Samples
collected through the IV often produced hemolysis in sample (Lippi et al., 2013a).
Venipuncture was the technique of choice for phlebotomy, but for patients in the ED, the
use of phlebotomy through IV was unavoidable. A prospective study evaluated SMonovette® serum tubes using manual aspiration as a tool to reduce erythrocyte injury in
blood drawn from IV catheters (Lippi et al., 2013a). Results proved that manual
aspiration using S-Monovette® serum tubes minimized stress on the IV line and reduce
the likelihood of hemolysis when compared to standard vacuum tubes.
Current recommendations from the CLSI suggested using end-point measurement
to reject hemolyzed specimens caused by possible clotting factor activation or
interference (Favaloro et al., 2012; Plebani, 2012a). A systematic approach to identify
hemolysis in samples was highly supported by clinical laboratory professionals because
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of the high prevalence of unreliable results affecting clinical decisions. The standard
practice to detect hemolyzed specimens was visual assessment, but this technique proved
to be unreliable (Dolci & Panteghini, 2014). This technique proved to be ineffective in
detecting slightly hemolyzed samples, was difficult to standardize, and had poor
reproducibility. Automated assessment of the hemolysis index (HI) was a possible
solution to detect the presence of cell-free hemoglobin in the sample.
Clotted samples were another cause of rejected samples in the preanalytical phase.
Standard practice requires the visual inspection of the collection tubes for the presence of
clots prior to centrifugation (Funk et al., 2012). Another method used to detect clot was
to inspect the sample in a backlit setting. Improper mixing of blood after collection was
the main reason for clotted samples (Upreti et al., 2013). Inadequate quality control
during preparation of EDTA vials was another reason for clotted blood. While clots were
easily detectable, microclots were difficult to detect and led to erroneous results.
Microclots interfered with results by activating factors and platelets (Funk et al., 2012).
Rejection of samples must occur if there is a suspicion of clots.
Well-documented studies revealed clotted samples as the main reason for
specimen rejection. These studies evaluated rejection criteria, including specimens
without barcodes, incorrect test requests, unsuitable container or tube, inappropriate
specimen, insufficient volume, incorrect timing of sample, incorrect storage,
inappropriate transport conditions, lipemic specimen, hemolytic specimen, and clotted
specimen (Lay, Pinar, & Akbiyik, 2014). One study revealed that the specimen rejection
rate was 2.7%, and clotted specimen had the highest rejection rate of 55.8% (Lay et al.,
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2014). Another study performed at a university hospital in Porto Allegre concurred that
clotted samples were the leading cause of specimen rejection (43.8%) (Guimarães et al.,
2012). A third study identified clotted samples as the most common reason for rejection
at 51.2% (Bhat et al., 2012).
Centrifugation. The majority of analytical specimens required for laboratory tests
are plasma or serum (Yilmaz et al., 2012). Centrifugation is a specimen handling process
to remove plasma or serum from blood components such as red blood cells, white blood
cells, and platelets (Koenders, van Hurne, Glasmacher-Van Zijl, van der Linde, &
Westerhuis, 2012). The application of centrifugal force separates the liquids of different
densities (Yilmaz et al., 2012). The designs of centrifuges are with or without
temperature control and different types of rotors. The steps involved with centrifugation
include queuing, loading, balancing, centrifuging, deceleration to a stop, and uploading of
the centrifuge. Centrifugation variables such as time, speed, and temperature can affect
certain analytical outcomes.
Centrifugation can take as long as 20 minutes, and with the added pressures from
clinicians for quicker turnaround time, laboratories explored avenues to reduce the
duration of this process (Koenders et al., 2012). A comparison of 50 plasma and 50
serum samples centrifuged at 5 and 10 minutes at a centrifugal force of 1885 x g
indicated that reducing the centrifugation time to 5 minutes did not affect laboratory
results using serum. However, reducing the centrifugation duration to 5 minutes of
plasma affected lipemic samples. The turbidity caused by lipemia interferes with certain
laboratory tests (Simundic & Lippi, 2012). Tests affected by lipemia included, but were
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not limited to phosphorus, creatinine kinase, total protein, alanine aminotransferase
(ALT), aspartate aminotransferase (AST), bilirubin, and latent iron-binding capacity. A
separate experiment showed that lipemia decreased by 50% when centrifuged for 10
minutes (Koenders et al., 2012). Ultracentrifugation and micro-centrifugation procedures
could remove lipemia from the sample (Simundic & Lippi, 2012). The conclusion was
that scaling the centrifugation time to 5 minutes would not affect most analytical results
and improved turnaround time (Koenders et al., 2012). The caveat of this conclusion was
that laboratories should implement precautionary measures to monitor lipemic samples.
The lack of standardization of centrifugation speed on platelet activity prompted
the need to investigate the effect of centrifugation speed on platelet activity (Merolla,
Nardi, & Berger, 2012). Venous blood tubes from 10 healthy patients were centrifuged
at 150, 200, 300, and 500 x g for 10 minutes. Results demonstrated that centrifugation
speed decreased platelet count, mean platelet volume (MPV), and platelet aggregation at
higher centrifugal speed. Decreased platelet count and MPV were the effect of higher
numbers of platelets (small or large) removed from plasma caused by increased relative
centrifugal force (RCF). Consequently, the removal of large platelets from the plasma
caused decreased platelet aggregation. Standardization of centrifugation parameters for
assessing platelet activities prevented ambiguous results (Merolla et al., 2012).
A precursor that promoted a study to appraise the effect of centrifuge temperature
on enzymes and thyroid panel results was a problem with the electrolyte testing in their
central biochemistry laboratory (Yilmaz et al., 2012). Technical staff reported gel
contamination in serum separator tube. Initial investigation revealed that centrifuges
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without temperature control might create heat, leading to the deterioration of the gel. The
National Committee for Clinical Laboratory Standards (NCCLS) guidelines advised
using temperature control for temperature sensitive analytes because centrifuges could
create internal heat. A comparison of 42 patients (84 blood samples) in temperature
controlled centrifuges and centrifuges without temperature control revealed the effect of
centrifugation temperature on certain analytes. Results indicated that ALT and thyroid
stimulating hormones values were significantly lower when spun in centrifuges without
temperature control. However, free triiodothyronine and free thyroxine levels were
higher in temperature controlled centrifuges. The authors warned that laboratories should
be aware of possible internal heat production effects on analytical results.
Awareness of centrifugation variables is essential for producing high quality
laboratory results. Variables such as centrifugation speed, time, and temperature could
affect certain analytical results. Standardization of these variables would ensure
laboratories are using the correct centrifuge parameters to decrease erroneous results.
Sample transportation. Sample transportation is a major contributor to delays of
clinical laboratory results to inpatients and outpatients (Zaninotto et al., 2012b).
Specimen transportation activities include duration of transportation, proper storage (time
and temperature) of sample, packaging criteria and sample position during transport,
identification of acceptability or rejection criteria of the samples and physical injury
(Lippi & Simundic, 2012; Zaninotto et al., 2012a). Monitoring of these activities
alleviated the reporting of inaccurate results resulting in detrimental effect on patient care
(Funk et al., 2012). Proper transportation of blood specimens after collection ensured the
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quality of sample (Rana, 2012). Some specimens required immediate transportation to
the laboratory for testing while others required centrifugation and separation within 2
hours. The recommended position of sample transportation was in an upright position
(Funk et al., 2012).
Increased pressure to reduce health care costs forced many organizations to
centralize and consolidate laboratory activities (Plebani, 2012a). The economical and
clinical advantages of consolidation and centralization of laboratory activities is still
unclear (Da Rin & Lippi, 2014). Consolidation resulted in major changes to workflow
and activities (Zaninotto et al., 2012a). Logistics of sample transportation is one area
heavily affected by change in the health care landscape. With the centralization and
consolidation of laboratory activities, the transportation of large numbers of specimens
from satellite collection sites to core laboratories is more prone to errors. This change
carries inherent risks for specimen integrity. The assurance of appropriate sample
transportation procedure is important to preserve the integrity of the sample to produce
high quality results.
Findings from the last few years exposed the effects of high speed pneumatic tube
systems (PTS) (Plebani, 2012a). The adoption of PTS in medical facilities was meant to
speed delivery of samples. The force exerted by PTS could cause physical trauma (i.e.
hemolysis) to samples to some extent and change the concentration of some analytes as a
result. PTS affected the results of certain analytes while others remained unchanged
(Funk et al., 2012). A comparison between manual versus PTS sample deliveries
signified that PTS added a significant bias to lactate dehydrogenase and magnesium test
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results, while PTS did not affect other analytes (Sylte, Wentzel-Larsen, & Bolann, 2013).
PTS may cause the cells to lyse and leak through the cell membrane resulting in
interferences with the test results. The recommendation was for hand delivery of tests
affected by rapid acceleration and deceleration forces in PTS.
Inappropriate temperature exposure during transportation, and delayed delivery of
samples were two known variables that played a significant role in the quality of
biological samples (Zaninotto et al., 2012a). Improper maintenance of samples at
inappropriate temperature might accelerate degradation (Funk et al., 2012). For example,
extreme exposure to inappropriate temperature could occur if staff leaves whole blood in
laboratory collection boxes in the freezer or stored in a vehicle’s trunk without proper
insulation, and thus, produce inaccurate results. Many practitioners agreed to these facts,
but the number of studies addressing the effects of these variables is nominal. This
literature review found two studies exploring a remedy to address inappropriate
temperature and prolonged transportation times (Zaninotto et al. (2012a; 2012b). The
authors implemented an integrated transportation system, and studied the effectiveness of
this system over a period of five years in one study (Zaninotto et al. (2012a). This system
was comprised of secondary and tertiary containers, a temperature and time recording
device, and a system allowing managers to determine the suitability of the samples based
on a visual analysis. The integrated system allowed for monitoring the temperature of
biological samples and transportation time throughout transportation, from the collection
center to the core laboratory. A second comparative study analyzed the effectiveness of
the implementation of the integrated system at reducing biases of six analytes (Zaninotto
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et al., 2012b). Collection of data occurred before implementation (2007) and after
implementation (2011) of the novel system. The study disclosed that improvement of the
quality of samples resulted for thee of the six analytes after the implementation of the
integrated system. Both studies took place at the University Hospital of Padova in Italy,
and concluded that the implementation and monitoring of integrated transportation
systems effectively optimized the transportation condition, prevented possible
interferences, and improved preanalytical quality.
Sample transportation condition depends on the test ordered, distance, and time
required between collection and analysis (Funk et al., 2012). Guidelines from the CLSI
recommended the centrifugation of blood samples to remove blood cells from plasma or
serum prior to transportation (Da Rin & Lippi, 2014). This process might prevent the
deterioration of several analytes that could occur during transportation. There was
evidence that prolonged contact of serum or plasma with blood cells can produce
erroneous results with several analytes. The underlying assumption is that the integrity of
centrifuged gel tube samples is intact if transported correctly. Determined to prove this
assumption, two researchers performed a comparative study assessing the effect of
transportation between centrifuged serum gel tube and lithium heparin gel tube (Da Rin
& Lippi, 2014). There was consensus that centrifuged specimens were safe during
shipment, but this study illustrated that ineffective transportation could compromise the
integrity of the lithium-heparin gel tubes. Evidence from data collected from 30 random
outpatient clinics indicated that serum gel tubes were a better choice for medium term
transportation while lithium heparin gel tubes had the tendency to produce greater biases
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in certain analytes post transportation. The recommendation was to centrifuge and
aliquot samples prior to transportation to avoid significant physical trauma (Funk et al.,
2012).
Failure to recognize the importance of specimen transportation can lead to
unreliable test results affecting patient care. Implementation of an integrated
transportation system could mitigate errors during specimen transportation and this
method was relatively inexpensive (Lippi & Simundic, 2012). Another strategy to
obviate errors during specimen transportation was to use serum gel tubes (Da Rin &
Lippi, 2014). Another suggestion was to implement accurate standard operating
procedures (SOPs) to standardize the processes in specimen transportation to reduce
errors (Lippi & Simundic, 2012). Laboratories must implement, review, or revise their
SOPs to ensure that their facilities are adhering to the proper guidelines to reduce
preanalytical variables.
Quality Management
The beginning of the 21st century marked concerted efforts to improve patient
care quality. It became a priority, and the focus, in all health care sectors (Allen, 2013).
The 1999 publication of the U.S. Institute of Medicine report To Err is Human: Building
a Safer Health System (Ram & Boermeester, 2013) prompted this movement. This report
cited as many as 98,000 deaths each year from preventable medical errors. In 2002, Sir
Liam Donaldson, the Chair of the World Health Organization’s World Alliance for
Patient Safety emphasized the importance of improving patient safety within laboratory
medicine (Agarwal et al., 2012). Producing high quality laboratory results was a priority.
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Quality in the laboratory is achievable through accreditation and quality management
systems (Hammerling, 2012).
QMS is a tool used to control laboratory processes in a systemic and transparent
way (Agarwal et al., 2012). Included in QMS are all activities involved with the
operation (i.e. instruments, facilities, and people). QMS is also valuable to identify and
implement strategies to ensure consistent high quality products (Munechika et al., 2014).
Leaders adopted QMS to drive and sustain continual improvement through regular
training and education of laboratory staff, introduction of automated technology, and
internal audits at the work site (Bhat et al., 2012). This system encourages a quality
oriented organizational structure and a positive work environment that benefits patients.
Growing evidence affirmed that QMS has the ability to improve clinical operations as
well as improve financial performance and increase employee satisfaction (Olofsson et
al., 2013). QMS should have a quality assurance (QA) program and quality indicators
(QIs) to monitor and ensure quality in a systematic way.
Quality assurance. QA is the systematic monitoring and evaluation of safe
practices and it benchmarks practices from one laboratory against another to ensure that
the operation is meeting the standards of quality (Plebani et al., 2014b). Accomplishment
of laboratory QA is through accreditation, internal quality controls (IQC), and external
quality assessment (EQA) (Berwouts et al., 2012). Accreditation ensures that
laboratories have a system of standard procedures to perform theirs processes correctly to
obtain quality results (Barth, 2012). The purpose of IQC is to monitor consistency over
time and to minimize variation, determine expected distribution of values, calculate mean
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and standard deviation, define limits for expected and unexpected results, and identify
unexpected values (Lee, 2012). EQA provides a platform to assess laboratory
performance by objectively comparing results from different laboratories (Berwouts et
al., 2012).
Accreditation. The laboratory industry improved quality through efforts such as
laboratory automation, laboratory consolidation, and accreditation of laboratories
(Christian, 2011). As part of these efforts, accreditation played an important role in
quality management. Accreditation was defined as the oversight of safe practices from
accrediting organizations, comprised of professional groups, to ensure quality when
delivering service (Hawkins, 2012). Accreditation is designed to monitor whether
laboratories have standard procedures to perform their processes correctly to produce
quality results (Barth, 2012). Organizations involved with measuring quality in
laboratory services are the Clinical Laboratory Improvement Amendment (CLIA), the
College of American Pathologist (CAP), The Joint Commission, and the International
Organization for Standardization. These organizations work closely with one another to
ensure quality in the laboratories.
The Centers of Medicare and Medicaid Services (CMS) is a governing
organization regulating testing quality as required by CLIA (Hammerling, 2012). CLIA
provides comprehensive standards for all laboratories to follow to assure quality
standards in laboratory testing. The Clinical Laboratory Improvement Amendments of
1988 (CLIA 88) emerged because of the media’s attention to quality problems in medical
laboratories (Christian, 2011). Prior to the enactment of CLIA 88, there was a lack of
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regulation in laboratory services. Standards for qualifications of technical personnel,
supervisors, and laboratory directors did not exist. Problems associated with unregulated
laboratories include lower accuracy and unreliability of test results.
CLIA 88 provides a foundation for clinical diagnostic laboratory operations
because all laboratories, regardless of whether they receive payment from Medicare or
Medicaid programs, must have a current and valid CLIA certificate to test human
specimens. CLIA 88 is the primary source of regulations addressing laboratory quality
and quality assurance. The objective for establishing CLIA 88 was to ensure reliable and
accurate laboratory testing with a concentration on quality controls, proficiency testing,
credentials of laboratory testing personnel, requirements for result reporting, and
appropriate documentation of standard operating procedures (Weiss, 2012).
CLIA 88 defined clinical laboratories as any facility analyzing human materials
for providing information to clinicians for diagnosis, prevention, or treatment of any
condition or assessing the health of human beings (Weiss, 2012). CLIA 88 specifies that
all laboratories performing the same tests must follow the same standards or guidelines.
CLIA 88 allows only qualified personnel to perform or supervise testing. CLIA 88
further subdivides personnel qualifications according to the complexity of testing. The
program also defines requirements for laboratory directors and analytical staff according
to laboratory category. CLIA 88 also mandates required periodic inspections by
accreditation bodies (Howerton et al., 2010). CAP primarily leads the Laboratory
Accreditation Program, but other accreditation bodies, including TJC and state health
departments, also perform laboratory inspections (Weiss, 2012). CLIA 88 also requires
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clinical laboratories to enroll and participate in External Quality Assessment (EQA)
programs approved by the CMS.
CAP Laboratory Accreditation Program is an international accreditation program
with the goal of improving quality in laboratory services through education, standard
setting, and ensuring the compliance of regulatory requirements (Hawkins, 2012). Over
6,000 laboratories worldwide obtained accreditation from CAP. CAP’s checklist
questions are clear with their intent, and compliance to the checklist questions is a
requirement to attain or maintain accreditation with CAP (Serteser et al., 2012). CAP also
requires laboratories to produce evidence of compliance. CAP checklists are a specific
discipline, and customized to each laboratory. The Laboratory General Checklist aims to
monitor the preanalytical and postanalytical phases, as well as CAP laboratory safety
goals.
CAP Laboratory General Checklist items are numbered. GEN.20348 monitors
the preanalytical phase processes of accuracy of transmission of test orders, specimen
transport and preparation, requisition accuracy, quality of phlebotomy services, and
specimen acceptability. GEN.20364 deals with postanalytical activities such as accuracy
of result transmission, turnaround time, and interpretation of results. Item GEN.20316
targets the preanalytical phase by requiring laboratories to have policies and procedures
for patient or specimen identification, test order accuracy, specimen acceptability, sample
labeling, and blood culture contamination.
Critical values are test results that could post a potential life-threatening situation
if the laboratory does not report the value to the nurse or physician upon discovery.
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GEN.20365 dictates that laboratories address CAP Laboratory Patient Safety Goals.
CAP conducts onsite inspections every two years to ensure compliance to the checklists.
Inspectors are practicing laboratory professionals using the checklists as a guideline.
Review of the CAP checklists occurs on a continuous basis.
CAP also developed two programs, Q-PROBES and Q-TRACKS, to identify and
monitor laboratory errors (McCay, Lemer, & Wu, 2009). Q-PROBES assesses all phases
of laboratory testing while Q-TRACKS monitors process, outcome, health status, and
patients’ perception of quality. To help laboratories assess their competency, CAP is a
provider of an EQA program. EQA directly compares methods and specific results of
participating facilities using statistical analysis.
The Joint Commission International (JCI) is the international branch of TJC
(Serteser et al., 2012). Since 1994, this branch has worked with health care organizations
in over 80 countries to achieve patient safety. To obtain and maintain accreditation from
JCI, health care organizations must implement the JCI International Patient Safety Goals
(IPSGs) (Hawkins, 2012). JCI developed six IPSGs to promote improvement in patient
safety. The first two IPSGs specifically targeted the preanalytical and postanalytical
phases of TTP. The first, IPSG 1, requires organizations to define a process to identify
patients accurately. This goal alleviates misidentification errors that could result in
inappropriate diagnosis or treatment. One in 18 misidentification errors resulted in
adverse patient experience (Hawkins, 2012). JCI requires the verification of two forms
of identification when collecting or dispensing blood for clinical use. IPSGs expect
laboratories to develop a process to communicate effectively between caregivers. This
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goal applies to the preanalytical and postanalytical phase where communication is
important to quality improvement. Preanalytical and postanalytical phases involve
different care providers, including but not limited to, doctor, nurses, and laboratory
personnel. Communication between these caregivers is essential to improve patient
safety. In particular, this goal mandates defined policies and procedures for verbal and
telephone requests and the read back of critical test results. Policies and procedures for
verbal and telephone requests and read back of critical test results must include entering
the order into a computer, reading back the order, and confirmation of what was written
down and read back. These IPSGs force health care organizations to define processes to
improve quality in laboratory practices. In addition to these IPSGs, onsite inspections
take place on a three year cycle to ensure that laboratories can produce evidence of
compliance.
ISO 15189 is an international accreditation organization that specifies quality and
competence requirements for medical laboratories (Serteser et al., 2012). ISO 15189 has
standards that address preanalytical, analytical, and postanalytical processes. To meet the
standards, laboratories must have complete procedures for all processes for TTP, and
these procedures should be available to staff performing the tasks (Allen, 2013). ISO
15189 requires laboratories to implement preanalytical procedures for ordering tests,
patient identification, collection of primary sample, transportation of samples, and
storage of samples. The requirements for the analytical phase include validation of all
procedures prior to implementation by comparing the results with already validated
procedures and training staff to perform the test and to trouble-shoot. Review of
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procedures must occur periodically. Postanalytical requirements are procedures for
reviewing and releasing results, proper storage of samples for repeat testing, and patient
report. ISO 15189 requires laboratories to adopt continual improvement by
systematically reviewing laboratory procedures for sources of nonconformity and
opportunities for improvement. To summarize, implementation of ISO 15189 has the
potential to contribute to patient safety by providing a foundation for quality with their
defined standards targeting laboratory practices.
Quality controls. Quality controls (QC) are operational techniques and activities
used to fulfill requirements for quality assurance (Lee, 2012). The intent of QC in the
laboratory is to monitor the performance of test procedures to ensure accurate results
and to alert when potential failure might occur (Ceriotti, Brugnoni, & Mattioli, 2015;
Njoroge & Nichols, 2014). Measurement of QC is a means to detect systematic errors
and to prevent laboratories from releasing erroneous results. QC includes all activities
performed to assure continuous monitoring of the performance of the analytical system
and to alert when an analytical process fails to meet the predefined analytical goals
(Ceriotti et al., 2015). ISO 15189 requires laboratories to developed QC procedures
designed to ensure precision and accuracy of test procedure.
When developing QC procedures, CLSI C243-A3 outlined several required steps
(Ceriotti et al., 2015). The steps involved are (1) define the quality specification for the
test, (2) select the appropriate control material, (3) determine the performance
characteristics of the measurement procedure, (4) identify which QC material to use, (5)
predict the possibility that the QC material will be out of specification performance, (6)
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specify expected goals of QC performance, and (7) select QC material with performance
that meets or exceeds the QC performance goals. The steps described above provide a
guide for laboratories to follow when developing and implementing QC procedure.
Liquid QC material is a common way to monitor the performance of an analytical
system (Njoroge & Nichols, 2014). Liquid QC is effective in detecting errors caused by
incorrect technique by the operator or incorrect reagent preparation affecting QC and
patient results. Laboratories test QC material in the same manner as patient samples.
Standard operating procedure should outline the frequency, QC performance, control
rules, and acceptable ranges. SOP should also describe acceptance and rejection criteria
for QC results. The frequency of performing QC should conform to regulations set by
the accreditation agencies. When QC result is out of range, and deemed as unacceptable,
the laboratory cannot analyze or release patient test results. Operators are to monitor the
QC data for shifts and trends to detect potential issues with the instrument or reagents.
One limitation of liquid QC includes the inability of the material to detect random
and unpredictable errors such as hemolysis or lipemia (Njoroge & Nichols, 2014).
Another limitation is the inability of liquid QC to detect preanalytical errors such as
specimen mislabeling or postanalytical errors such as incorrect result entry. To mitigate
the risks posed by liquid QC, various test systems employed alternative QC strategies in
addition to liquid QC. New laboratory instruments incorporated bubble, clot, and
hemolysis electronic check into the test system to address these possible errors. Some
point of care systems incorporated internal quality control into the test devices to ensure
test results were accurate.
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Previous studies indicated that regulatory bodies, laboratory professionals, and the
diagnostic industry focused on improving errors in the analytical phase of testing
(Plebani, 2013). Errors in this phase of testing significantly decreased because of strict
controls using QC materials. In the 1950s, the introduction of QC for the analytical
phase aimed to ensure quality. Laboratory workers dedicated themselves fully to
improve quality in this phase (Majkić-Singh & Šumarac, 2012). With analytical errors in
check, laboratories need to shift the paradigm and implement QC for the preanalytical
phase of testing. Although practitioners call attention to QC in the preanalytical phase,
the literature review exposed an apparent gap because QC programs targeting the
preanalytical phase are nonexistent.
External quality assessment. Accreditation bodies require medical laboratories
to participate in an EQA program (James et al., 2014). EQA programs are useful to
assess quality assurance in medical laboratories (Berwouts et al., 2012). Laboratories
must participant in EQA schemes to maintain accreditation. The majority of laboratory
professionals worldwide consider EQA and Proficiency Testing (PT) to be the same
(James et al., 2014). Objectives for EQA and PT are different, though laboratory experts
use these terms interchangeably. EQA focus on self-assessment and continuous
improvement of quality for the benefits of the patients. PT, on the other hand, is a
program where participating laboratories receive and analyze results with those of their
peer group. For the purpose of this literature review, the term EQA represents both
terminologies.
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EQA serves as a tool for medical laboratories to confirm when tests are
performing correctly, to alert when potential issues with the test arise, and to confirm
when a test is performing well (Jones, 2015). EQA programs assess accuracy, precision,
bias, analytical specificity, interferences, units, reference intervals, calculation, and
interpretation of an assay. EQA and PT serve to provide reliable information to allow
laboratories to assess and monitor the quality status of internal procedures and processes,
the suitability of diagnostic systems, the accountability and competence of the staff, and
uncertainty in laboratories results. The correct use of EQA could result in improvement
of laboratory performance. EQA allows laboratories (1) to analyze appropriately and
investigate root causes producing unacceptable results, (2) to detect trends of laboratory
bias that might not be apparent from a result, and (3) to determine whether the problems
could affect clinical decision-making. Participating laboratories, professional
organizations, health-care providers, and health funding bodies view EQA data to judge
the competence of laboratories. Manufacturers also use this data to monitor the analytical
performance of their tests, post market release. The availability of proficiency testing
results allows the public to assess the performance of a particular laboratory (Christian,
2011).
EQA programs should select samples appropriately to reassure laboratories that
their test has the potential to achieve the highest standard of quality (James et al., 2014).
Samples should mimic actual patient samples. Samples included in EQA should
represent an appropriate range of values that could affect clinical decision. Participating
laboratories should incorporate EQA samples into the normal flow of patient samples.
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EQA requires laboratories to treat specimens as routine samples, and specifies that the
government has the authority to perform onsite inspection to ensure equal treatment of all
samples.
Multiple benefits of EQA programs include improving patient safety, minimizing
test bias and imprecision, identifying interference substances across multiple methods,
identifying laboratories with subpar performance, and satisfying requirements for
accreditation and regulatory bodies. The effectiveness of EQA programs depends on two
factors: the design of EQA schemes, and the procedures laboratories used to evaluate
samples. Studies demonstrated laboratories participating in EQA showed improved
laboratory performance. Laboratories can use the results provided by the programs to
investigate the root causes of defects and implement effective measures to eliminate
errors.
The steps involved with EQA programs are (1) the EQA provider prepares and
distributes the samples to participating laboratories, (2) laboratories analyze the samples
and submit the results to the EQA provider, and (3) the EQA collates the results and
sends out reports to the participating laboratories (Jones, 2015). Then a designated
laboratorian, with appropriate competency to review the results, takes appropriate actions
to resolve incorrect responses (James et al., 2014). For example, laboratories need to
investigative and correct action plans if the laboratory exceeds the total allowable error
(Njoroge & Nichols, 2014). This signifies a possible drift of the test system when
compared to their peers. To maintain CLIA certification, laboratories must successfully
pass EQA for specific analytes with a score of at least 80% (Howerton et al., 2010). If a
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laboratory fails to achieve satisfactory performance for any analytes on two consecutive
challenges, CLIA can sanction the laboratory.
Existing EQA programs target the analytical phase, and programs addressing the
preanalytical phase are scant (Kristensen, Aakre, Kristoffersen, & Sandberg, 2014). The
challenge for accreditation bodies to develop EQA programs targeting the preanalytical
phase is that many processes occur beyond laboratory walls. The preanalytical phase
involves various locations, as well as health care professionals, and the laboratory does
not have direct control of these. EQAs focusing on the preanalytical phase are in the
development stage. Three types of preanalytical EQAs in development include Type I,
Type II, and Type III. Type I involves the circulation of questionnaires asking
laboratories to explain the proper procedures for handling certain aspects of preanalytical
processes. Type II circulates samples containing a matrix (i.e. hemolysis, lipemic, or
icteric) with the potential to interfere with results. Type III reports errors or adverse
events. Actual reporting of analytical errors will provide laboratories with a platform to
gauge the challenges faced by their peer group (Lippi et al., 2015). The three types of
EQA have different focuses, but a combination of the three is probably necessary to
detect and monitor the broad spectrum of preanalytical errors.
Another aspect to include in the EQA scheme is to provide a feedback report for
all types for comparison of laboratory results to all participants. Included in the feedback
report is an overview of existing guidelines or recommendations, as well as strategies to
minimize errors. Challenges to developing EQA programs for the preanalytical phase
exist; EQA organizations must make efforts to develop these programs because this phase
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is more prone to errors than the other phases of TTP.
Accreditation, QC, and EQA are important programs for assessing quality
assurance in medical laboratories. The CLIA, CAP, TJI, and ISO 15189 have the
capabilities to guide clinical laboratories with quality assurance. Accreditation ensures
that laboratories are performing all their processes correctly (Barth, 2012). QC and EQA
programs allow laboratories to measure, monitor, and improve their analytical
performance in a systematic way through a period to time (Plebani, Sciacovelli,
Marinova, Marcuccitt, & Chiozza, 2013b). These programs provide medical laboratories
with a means to benchmark their performance based on objective data.
Quality indicators. Much of the research into quality measurement focused on
the use of quality indicators. Setting high quality standards in laboratory medicine is
essential because clinicians used results generated by laboratories in diagnosing and
treating patients (Hammerling, 2012). Developing and implementing reliable QIs can
facilitate the achievement of quality of laboratory services (Plebani et al., 2013a). All
laboratories should establish QIs to monitor their processes and assess possible errors
(Majkić-Singh & Šumarac (2012). QIs are primary tools allowing users to measure and
monitor quality improvement by comparing it against defined criterion (Plebani et al.,
2013b). When implementing QIs, users can choose from two types of QIs (Barth, 2012).
The first type monitors progress and improvements as well as possessing a system to
investigate and correct errors when they occurred. These indicators include operational
metrics and comparing results with peer groups. The second type of QI monitors
turnaround time, test costs, and complaints. These indicators aim to evaluate
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performance management and accountability. Collection of QI data should be sufficient
to identify, correct, and continuously monitor defects and implement corrective or
preventive actions (Plebani et al., 2013a). QIs are only effective with useful outcomes if
there is clarity when delivering objectives and goals (Barth, 2012). QIs should be part of
the quality improvement strategy. The design of QIs should include metrics that meet the
requirements for the needs for improvement and performance management, and be
measurable.
QIs allow laboratory managers to quantify the quality of their services (Plebani,
Sciacovelli, Aita, Padoan, & Chiozza, 2014c). Current QIs concentrate on the analytical
processes to monitor performance and efficiency of the operational processes (Barth,
2012). An apparent gap in laboratory quality management is the lack of concentration on
the preanalytical phase, though there is insurmountable evidence that the majority of
errors occurred in this phase (Lima-Oliveira et al., 2012). Correction of preanalytical
errors requires laboratories to identify QIs in the preanalytical phase. The lack of
standardization of phlebotomy is an important aspect where applying proper technique
will ensure high quality results. An awareness of the importance of preanalytical phase
will prompt expansion of national and international quality assurance programs to
address quality issues in this phase (Guder, 2014). There is a need to develop an
international standard of QI that will cover the entire spectrum of TTP (Plebani et al.,
2013a). Traditionally, QIs in preanalytical errors include sampling errors that were
composed of rejected samples, patient wristband misidentification, timing errors in
sampling and preparation, inappropriate sample transport, and inadequate sample (Atay et
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al., 2014). However, QIs expanded to include appropriate test request and complete
request forms (Plebani et al., 2014c).
Accrediting bodies shifted their focus to measure quality indicators. In the U.S.,
the Division of Laboratory Systems in the Center of Disease Control (CDC) drives the
initiative to improve quality in laboratory medicine (Barth, 2012). Their goal is to
examine clinical quality and develop best practice guidelines. There was a pilot program
testing a new method to promote quality improvement in laboratory medicine. This
group identified 14 QIs in laboratory medicine to prevent errors. These included test
order appropriateness, wristband identification errors, patient satisfaction with
phlebotomy, specimen quality, proficiency performance, cervical cytology-histology
mismatch, availability of inpatient results, corrected laboratory reports, critical value
reporting, turnaround time, clinician satisfaction, and follow up of abnormal cervical
cytology. The CDC encourages continuous collaboration between laboratory
professionals to identify good practices. ISO 15189 also recognizes the importance of
QIs to evaluate, monitor, and improve procedures and processes in the preanalytical
phase (Plebani, 2014). QI could also identify errors and non-conformities occurring in all
steps involved with preanalytical phase. In 2008, The International Federation of Clinical
Chemistry and Laboratory Medicine (IFCC) introduced a working group known as
Laboratory Errors and Patient Safety (WG-LEPS) with the sole purpose of identifying
and evaluating applicable QIs in all phases of testing (Plebani et al., 2013b). According
to WG-LEPS, the QI developer should consider four criteria. The first criterion requires
QI to be relevant and applicable to all clinical laboratories on an international level. The
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second requires it to focus on important medical laboratory quality issues based on
scientific evidence. The third notes that QI should be measurable, with available data and
defined acceptable thresholds. The fourth requires QI to serve as a measure of laboratory
improvement. WG-LEPS developed the model of quality indicators (MQI) as a tool to
promote investigation into errors in laboratory medicine, to collect data available on this
issue, and to recommend strategies and procedures to improve patient safety (Plebani et
al., 2013a). MQI consists of 56 quality indicators, of which 34 are for the preanalytical
phase, seven for the analytical phase, and 15 for the postanalytical phase (Lippi et al.,
2013b). The purpose of MQI is to provide a standardized structure for laboratories
worldwide to report and collect comparable data. MQI also allows laboratories to analyze
quality issues that could have potential effects on patient care.
In summary, QIs are fundamental tools that could provide sound evidence of
quality in all procedures and processes in TTP (Plebani, 2012a). Quality indicators are
useful to identify, address, and monitor performance measures in the testing process. A
study indicated that there was a reduction of preanalytical and postanalytical errors after
the completion of training on quality indicators (Agarwal et al., 2012). Errors
dramatically dropped for errors in the pre-analytical phase and showed almost 100%
improvements in the post-analytical phase after training. By identifying and monitoring
problems, the clinical laboratory can develop improved processes to enhance patient
safety. Quality indicators are effective tools in assessing and maintaining quality control
in a systematic and transparent way. However, the success of implementing and
monitoring QIs depends on the active involvement of all personnel performing the
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preanalytical processes. Implementation and monitoring will require extra resources
initially, but the reward will be the reduction of risk in errors, waste, and operation
repetition (Plebani et al, 2014b).
Various organizations developed QIs to monitor continuous improvement
activities aimed at alleviating errors in TTP. However, a disconnection between
organizations resulted in different meanings of QIs with different goals. In particular,
QIs in the preanalytical and postanalytical phases need further efforts from these
organizations to achieve consensus in developing, implementation, analyzing, and
monitoring of QIs. With different organizations launching their own version of QIs,
laboratory professionals need to standardize current initiatives and terminologies, and
develop QIs to address errors occurring in all processes of TTP (Plebani et al., 2013).
The implementation of QIs is an essential component to monitoring continuous quality
improvement programs (Plebani et al., 2014b). Quality indicators are useful for
highlighting critical processes, analyzing root causes of nonconformity, reducing risk for
errors, and improving laboratory performances.
Summary. Quality management of the preanalytical phase is achievable through
consistent and continuous application of an evidence-based approach (Plebani et al.,
2015). Evidence based approaches require laboratories to closely monitor their
processes, implement a system to detect errors, and perform root cause analysis when the
same error occurs frequently. QA and QI are two avenues that can aid medical
laboratories in monitoring quality in their organizations. QA activities such as
accreditation, QC, and EQA can provide laboratories with platforms to assess their
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performance against the accreditations’ defined standards and benchmark their
performance with peer groups. QI can provide medical laboratories with fundamental
tools to quantify their quality. As discussed above, apparent gaps exist pertaining to the
quality management activities for the preanalytical and postanalytical phases. The
medical laboratory industry needs to shift the focus of quality from the analytical phase to
TTP. Total quality is achievable if quality management activities encompass all phases
of TTP.
Possible Preventive Measures
Errors in health care that resulted in premature patient deaths are unacceptable,
especially with cases where the medical error was preventable (Simundic et al., 2015).
Laboratory errors can lead to diagnostic errors and reports indicated that laboratory
contributed to approximately 40% of diagnostic errors. This literature review exposed
two themes of possible preventive measures to mitigate preanalytical errors:
harmonization and technological advancement. The harmonization of laboratory results
occurs when results are comparable, regardless of the method used to measure the
analytes (Miller, Tate, Barth, & Graham, 2014). Technological advancement is the use of
technology to eliminate or minimize manually intensive processes.
Harmonization. The majority of laboratory errors occur in the preanalytical
phase. The high prevalence in the preanalytical phase is the result of processes occurring
outside of the laboratory, the involvement of numerous professions, inconsistent
procedures, and low compliance with procedures. The fragmented practices of the
preanalytical phase are in need of standardization and harmonization to mollify errors in
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this phase. The laboratory industry has developed and implemented standardization and
harmonization initiatives for the analytical phase (Aarsand & Sandberg, 2014). It’s time
to shift the paradigm to standardize and harmonize preanalytical phase processes.
International and national organizations recognized that harmonization initiatives are
essential to improving processes in the preanalytical phase. Any initiative will take the
collective efforts of all stakeholders involved.
International efforts. International efforts to harmonize preanalytical phase
activities are limited, and there is opportunity for improvement in the medical laboratory
profession in this phase (Miller et al., 2014). Organizations that can potentially influence
harmonization on an international level are European Federation for Clinical Chemistry
and Laboratory Medicine (EFLM), the American Association of Clinical Chemistry
(AACC), IFCC, and Consortium for Harmonization of Clinical Laboratory Results
(ICHCLR). Efforts implemented by these organizations, and regulatory accreditation
bodies such as ISO can help with harmonization by developing standards to guide the
laboratories (Miller et al., 2014). ISO 15189 requires that laboratories develop,
implement, and monitor QIs for all phases of TTP.
The EFLM has special interest to address harmonization in all processes of TTP
(Simundic et al., 2015). Their goal is to contribute to the improvement of the quality
delivered by laboratories. In efforts to achieve harmonization in the preanalytical phase,
the EFLM and its Working Group for Preanalytical Phase (WG-PRE) decided to be the
catalysts on several international projects (Lippi et al., 2015). Issues addressed by WGPRE include test request, test selection, appropriate training, sample handling, and
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application of QIs. EFLM believes that harmonization of the preanalytical phase will
reduce the potential risk of errors and improve patient safety. EFLM is also soliciting the
collaboration of laboratory professionals, health care practitioners, manufacturers, and
accreditation bodies on the journey toward harmonization. The goal of EFLM is to
encourage these groups to define a universal, acceptable, and applicable standards, and
global implementation. EFLM will facilitate dialog between all interested parties.
Interested parties have the opportunity to participate with the establishment of
standardized procedures for preanalytical processes and help accreditation bodies to
update existing recommendations. In contrast to the AACC’s harmonization projects for
the analytical phase, EFLM is raising awareness for the need of harmonization in the
preanalytical and postanalytical phases of testing. EFLM established a new Working
Group for Harmonization of TTP (WF-H) to achieve this goal. To achieve this goal, WFH has to identify the critical areas that need harmonization. WF-H needs to be the
coordinator and facilitator for initiatives on a national and international laboratory
community. They also have to be the bridge between other working groups within EFLM
and ISO organizations.
Another organization with a longstanding commitment in this area is the IFCC
(Miller et al., 2014). The IFCC developed MQI to provide a standardized structure to
report errors in the laboratory and to promote investigation when errors occurred (Plebani
et al., 2013). Ongoing projects from IFCC WG-LEPS will provide external databases for
comparison between laboratories and peer organizations (Plebani et al., 2014a). The
realization of laboratory goals and improvements in performance are reachable with these
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data. Current harmonization activities reached three agreements pertaining to QI values
(Plebani et al., 2014c). First, QIs are an essential tool for quality improvement. Second,
there is a need to comply with the current defined QIs. Third, there is consensus that
IFCC MQI is the initiator in the laboratory industry to standardize QIs. The current MQI
allows laboratories to select the most appropriate indicators applicable to their practices.
The future goal of WG-LEG is to promote a set of approved QIs and to collect data from
international laboratories to share the occurrence, root cause of laboratory errors, and
appropriate corrective actions, as well as monitoring the effectiveness of improvement
activities.
The formation of ICHCLR in 2013 was in response to the lack of coordination
and prioritization of harmonization activities to meet the needs of laboratory medicine
globally (Miller et al., 2014). ICHCLR was to provide a systematic approach to prioritize
critical areas in need of harmonization based on clinical significance and technical
feasibility, to act as liaison on global harmonization activities to avoid duplicate efforts,
and to develop standardize procedures. The ICHCLR website serves as a platform for
interested parties to obtain information on harmonization activities conducted by
organizations worldwide. Any interested party may become an active participant in
harmonization projects.
Preanalytical harmonization projects. The implementation of standardized
analytical techniques and reagents, advancement in instrumentation, and information
technologies resulted in a ten-fold reduction of analytical errors (Plebani et al., 2014c).
The lack of attention to the preanalytical phase allowed errors to flourish in this phase.
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The reason was that some procedures were not within the control of the laboratory.
Focus needs to change to be patient-centered; where both clinicians and laboratorians
work to develop safeguards to prevent errors. There is a need to develop fundamental
procedures and processes to guide clinicians and laboratorians to perform processes
correctly. Primary preanalytical phase processes in need of harmonization include
appropriateness of the test requests, correct patient identification, sample handling, and
QIs.
Test requests. Test requests are an area that has potential for harmonization
(Aarsand & Sandberg, 2014). The lack of standardization in tests to order for prevalent
diseases resulted in mismanagement of tests to diagnose patients. From this lack of
standardization, clinicians were unclear on test availability and the composition of test
profiles for different clinical conditions (Tate et al., 2014). Mismanagement of tests
affects finance, with increased costs for reagents, consumables, and human resources for
unnecessary consultations, treatments, and investigations (Plebani & Panteghini, 2014).
Laboratory leaders in various organizations on the national and international arenas are
addressing ways to harmonize test profiles for specific disease. Laboratories can also
influence the test request order by providing physicians with test order forms with
predefined tests that can optimize the use of laboratory resources from both a medical and
economic viewpoint (Aarsand & Sandberg, 2014). One strategy is to develop
predetermined test profiles for doctors according to the specific clinical situation. For
example, if the patient has signs and symptoms of a myocardial infarction, the physician
can order a test profile to diagnose this condition without wasting time and money on
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inappropriate tests. Another strategy is for laboratories to develop a system according to
problem-based requesting with algorithms for reflexive and reflective testing. For
example, if CBC results indicate that the patient might have thalassemia, the system
would order additional tests according to the predefined algorithms. Algorithms could
also prevent the order of repetitive testing. Another strategy is to standardize the
nomenclature for test procedures because of the growing adoption of computer systems to
order tests (Miller et al., 2014). Common terminologies would minimize the confusion of
which test to order, and provide a menu that would be the same, regardless of health care
organization. This would enable physicians to be consistent, and efficient, when seeing
patients at different institutions.
Several organizations released initiatives to harmonize laboratory test selection.
EFLM Working Group on Guidelines is working on a systematic way to harmonize test
selection according to the clinical presentation (Tate et al., 2014). The initiative launched
by the United Kingdom Quality and Outcomes Framework (QOF) set certain minimum
standards for testing activities with financial incentives (Lippi et al., 2015). This
initiative helped avoid under-testing, but there was a lack of initiatives to address overtesting. Efforts by the Catalonian Health Services developed a project to assess the
management of laboratory demands (Lippi et al., 2015). The variability of laboratory use
is wide and there is a need to standardize this demand. Strategies used to enhance use are
education and web site ordering for tests. As part of the core curricula, medical and
nursing universities are teaching the fundamental use of laboratory resources. The
adoption of software to order tests helps facilitate access to information and training,
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communication of test cost, test request according to patient clinical presentation, and
reduces or eliminates duplicate testing.
Test identification and sample handling. The most prevalent number of errors
occurring in TTP are patient identification and sample handling (Aarsand & Sandberg,
2014). IFCC suggested the percent of patient identification errors should be less than
0.4%. Procedures for proper patient identification can achieve harmonization through
guidelines and standards. ISO Technical Committee 212 is developing a document
addressing the quality practice in collection and submission of samples for laboratory
testing.
Harmonization of specimen collection and transportation could reduce variability
of results (Miller et al., 2014). Collection of samples in proper containers with the
correct specified amount reduces the risk of producing erroneous results. Proper
specimen transportation conditions preserve the integrity and stability of the samples.
Existing recommendations for specimen collection and transportation are inadequate, or
incomplete, making it difficult for laboratories to relay the guidelines to care providers.
The lack of standardization of specimen collection and transportation procedures
contributes to varied and erroneous results. Harmonization of specimen handling is
achievable through EQA organizations (Aarsand & Sandberg, 2014). Specimen handling
includes sample material, preparation, sample collection, sample stability, and
transportation of sample transportation.
EQA organizers can distribute samples to assess the laboratory’s ability to handle
samples. The ELFM-WG is addressing the standardization of sample collection
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procedures to minimize uncertainty during the preanalytical phase (Tate et al., 2014).
The success of harmonization activities is possible through monitoring. EQA is one
method that monitors harmonization activities. EQA has the ability to detect any
systematic drift in assay performance by comparing patient results with the peer groups
(Tate et al., 2014). To monitor harmonization efforts and effects, EQA organizations are
a natural choice in most settings, either by expanding existing schemes to assess other
relevant phases of the TTP or by setting up new scheme (Aarsand & Sandberg, 2014).
Quality indicators. IFCC-WG is leading efforts to identify QIs for the global
program of continual improvement (Tate et al., 2014). Quality indicators provide
laboratorians with tools to measure the quality of selected activities by comparing against
the benchmarked criteria (Plebani et al., 2014a). ISO 15189 mandates accredited
laboratories to develop QIs to monitor and evaluate the performances of all aspects of
TTP. ISO 15189 also stressed the need to assess QIs periodically for continued
appropriateness. Although laboratories complied with this requirement, the different
methods used to identify and manage QIs make it impossible to compare the results.
Harmonization of QIs allows laboratories to compare themselves against their peers to
ensure the deliverance of quality care. Accredited laboratories need to provide evidence
of implementation of QIs because QIs are the tools used to assure risk management and
promote patient safety (Plebani et al., 2014b). Although risk management assessment is a
requirement of ISO 15189, laboratories need to select appropriate QIs to implement from
the beginning, and to monitor the effectiveness of these QIs over time.
Harmonization of QIs needs to commence with the clear definition of QIs and to
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minimize the variety of existent QIs (Plebani et al., 2014b). Criteria for developing QIs
should be patient centered to promote quality and patient safety, consistent with
definitions of laboratory errors, consistent with accreditation organizations requirements,
applicable for promoting corrective or preventive actions, and address errors in all phases
of TTP. Once identified, to manage the defined QIs other issues to consider are the
standardization of systems for comparability between different laboratories and
collaboration between operators, within and outside of the laboratory. The consensus
among experts in the field is that harmonization of QI is achievable. Active involvement
between the physicians, phlebotomists, and nurses will improve the appropriateness of
test requests as well as the quality of samples (Plebani et al., 2014c). Validation of QIs
requires international consensus of criteria and management methods. Accreditation
providers will play a role in assuring laboratories are interpreting and applying ISO
15189 QIs requirements correctly. To encourage laboratorians to use QIs to measure
quality, accreditation and international laboratory professionals should provide clear
definition of QIs, and reward staff if applied correctly during survey visits.
Monitoring QIs performance in TTP will allow measurement and improvement of
quality of services (Plebani et al., 2014a). MQIs developed by the IFCC are a starting
point in promoting harmonization (Lippi et al., 2015); further efforts are needed to reach
a consensus on the roadmap for harmonization. Harmonization requires the collaboration
and active cooperation between health care providers from inside and outside of the
laboratory. As ongoing progress with harmonization continues to evolve, laboratory
leaders should advocate for the benefits of QIs as a tool to improve laboratory services
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and patient safety. Raising awareness of the importance of QIs as a quality improvement
tool is necessary to enhance laboratory services and patient safety.
Summary. Evidence shows that in the last four decades, there have been ongoing
efforts to harmonize laboratory processes and there is a continuous movement toward this
(Plebani & Panteghini, 2014). Relevant projects launched by various organizations
demonstrated that these projects play a pivotal role in the quality of laboratory medicine
(Tate et al., 2014). Harmonization might be a primary contributor to high quality in
laboratory testing (Aarsand & Sandberg, 2014). To date, the majority of the focus has
been on the processes within the laboratory because these processes are easier to control.
Harmonization goals should be applicable to all laboratory disciplines, from test request
to communication of result, and require equal consideration (Tate et al., 2014; Aarsand &
Sandberg, 2014). Harmonization of operation procedures also has the potential to reduce
errors and improve patient safety (Tate et al., 2014).
The likelihood of successful harmonization will depend on the cooperation of
laboratories, organizations, and stakeholders from the laboratory and clinical fields
(Aarsand & Sandberg, 2014). A system to identify and monitor errors must be in place
prior to the development of harmonization initiatives. Another aspect to consider is how
to standardize reporting laboratory errors and the implementation of corrective actions for
these errors. Harmonization of these activities should improve quality in laboratory
medicine. The success of harmonization will require collective efforts from national and
international stakeholders (Tate et al., 2014). Development of harmonization initiatives
will require close interaction between stakeholders in the clinical laboratory community,
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diagnostic industry, clinicians, professional societies, IT providers, consumer advocate,
and government industry. Achieving harmonization is a journey that will require well
defined, and evidence based, procedures, transparent operations, effective
communication, collaboration with all stakeholders, and cooperation from all participants
(Plebani & Panteghini, 2014). To achieve this goal, there is a need for the involvement
of organizations such as EFLM to facilitate the dialog between the different groups, with
the intent to reach consensus in preanalytical standards (Simundic et al., 2015). Invited
stakeholders participated in the establishment of universal standards for the preanalytical
phase. The collective efforts should include accreditation bodies for their participation to
incorporate the agreed upon standards into their required guidelines.
Acceptance of the initiatives will depend on effective communication and
marketing strategies (Tate et al., 2014). Communication and marketing strategies should
explain the relevant changes and educate clinicians on the initiatives. Better
communication and collaboration between laboratorians and clinicians are essential for
the success of harmonization initiatives (Plebani & Panteghini, 2014). The rift between
these professions affects patient safety, and harmonization is a possible solution to bridge
the professions through standardized terminologies and procedures for TTP.
The speed to achieve harmonization will be faster for some processes, where
standardization and harmonization are already in progress (Aarsand & Sandberg, 2014).
Any harmonization initiative addressing quality in laboratory medicine will require
resources and funding. Experts also noted that harmonization is easier to achieve in
certain parts of the world. Harmonization of the TTP will be a challenge for the
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international laboratory community in the years to come (Aarsand & Sandberg, 2014).
For the benefit of patients, laboratory medicine must deliver optimal care without
potential harm. Substantial efforts are underway to advance the science and the technical
processes to achieve harmonization (Miller et al., 2014). Monitoring the adoption of
harmonization is also necessary to determine if it is effective (Tate et al., 2014). There is
a need to support and organize these efforts on a global scale to deliver cost effective and
clinically optimized laboratory medicine services.
Technological advancement. Technological advancements provide laboratories
with tools to produce high quality results while improving efficiency (Lippi, et al., 2014).
Automation involves the use of machines, control systems, and information technologies
to improve productivity (Lippi et al., 2014). Modern technological advancements in
laboratory medicine make it possible for laboratories to meet the demand of increasing
test requests, while providing quality performance and timely test results (Plebani et al.,
2014b). The drivers for automation include opportunity to simplify, reduce, or eliminate
repetitive, complex, and harmful processes that require human intervention. An
advantage of automation is its ability to produce results with a high degree of precision
and accuracy. Many clinical laboratories adopted automation to reduce variability with
sample identification, sorting, centrifugation, decapping, aliquoting, recapping and other
specimen processing processes. Advantages of automation are prevention and reduction
of human errors, process streamlining, consistent operating procedures, improved
productivity and throughput, improved turnaround time, improved patient and operator
safety, traceability of sample and data, and decreased operational costs while achieving
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full compliance with regulatory certification or accreditation procedures. Automation
experiments addressing preanalytical processes include computerized systems to address
test ordering and misidentification, laboratory automation systems (LAS) to address
specimen handling and transportation, and barcoding to identify misidentification.
Computerized systems. Computerized systems have capabilities to help
laboratories achieve error reduction in the preanalytical phase as well as decrease
operational cost. Implementation of computerized order entry can reduce preanalytical
errors (Hammerling, 2012). Clinicians can order tests directly through the computerized
order entry system, rather than by assigning a second person to transcribe orders; creating
the potential for errors. Laboratory information systems have the capability to perform
delta checks on patient results (Njoroge & Nichols, 2014). Delta checks are a preventive
measure used by laboratories to detect significant differences between the current and
previous test results for the same patient. Delta checks will flag and hold the
questionable result for operator review before release. This process is useful in detecting
preanalytical errors including mislabeled samples or incorrect patient identification.
Patient specimen and laboratory testing identification errors are the two leading
causes of laboratory errors (Snyder et al., 2012). Patient identification errors are
preventable and have the potential to cause patient harm. Eradicating patients’
misidentification would improve patient safety (Salinas et al., 2013). International
organizations recognized that errors with patient identity could produce serious harms to
patients if not prevented. Errors contributing to misidentifications are mislabeling tubes
or the misidentification of a patient. One root cause of error in patient identification is
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incorrect demographic data entry. The authors conducted a study to explore the
frequencies and consequences of incorrect demographic data in LIS. Clients had the
option to order the test via an electronic ordering system or manually. For one year, two
administrative assistants compared demographic data in the LIS to the one on the paper
request form to detect potential identification errors. Errors occurred less frequently with
electronic orders (Salinas et al., 2013). Placing test requisition into an electronic system
could help minimize errors with patient identity.
Automation, databases, and computers improved productivity by eliminating
tedious tasks, with substantial process improvement also creating a positive effect on
patient safety (Lippi et al., 2014). Unfortunately, technological advancements cannot
eliminate all errors occurring in laboratory medicine. One area that implementation of
technological advancement is not possible is in phlebotomy. Phlebotomy is a manual
process (Lillo et al., 2014). However, establishment of certain strategies to minimize
phlebotomy errors is possible. Lillo et al.’s study indicated an improvement in missing
samples after the introduction of a new process in the LIS (2014). The new program
allowed the LIS to have the capability of printing custom labels, which correlated with
each test request and corresponding tube. Results indicated that a customized label
system has the ability to avoid missing samples by printing labels according to test
requests. This technological advancement minimizes the potential of oversight from the
phlebotomists. The study also revealed that patient satisfaction, with respect to
phlebotomy, improved after the implementation of the custom label system. Another
strategy is robotic working stations to provide a set of labeled blood tubes on a single tray
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per patient to prevent misidentification (Hammerling, 2012). Automated phlebotomy
could minimize error in tray preparation.
Laboratory automated systems. In response to pressures to reduce operational
costs, improve quality, and to meet the demand of increased workloads, many medical
laboratories are migrating toward automating many of their processes (Sedille-Mostafaie,
Engler, Lutz, & Korte, 2013). In the early 1990s, the laboratory industry realized that
total laboratory automation (TLA) was the optimal solution to handling high throughput
of samples, labor shortages, and decreased operational costs (Sedille-Mostafaie, Engler,
Lutz, & Korte, 2013). Although TLA had the potential to accomplish the benefits
mentioned, many small laboratories were unable to implement TLA because of lack of
space and cost. As a result, manufacturers developed modular, task-oriented automation.
As part of TLA, automated specimen processors and transportation systems were
available, and proved to be effective at several large clinical laboratories. Modular
preanalytical processors were also available to handle stockyards, conveyor belt
transporters, centrifuges, decappers, barcode readers, aliquoters, and sorters.
The implementation of automation is common in several areas of diagnostic
testing, especially in clinical chemistry and immunochemistry (Lippi et al., 2014).
However, more complex testing such as hemostasis still requires the technical and
clinical expertise of laboratory personnel to interpret the results. A study compared
manual centrifugation and automated centrifugation to assess their influence on
hemostasis specimen processing (Sedille-Mostafaie et al., 2013). Optimal centrifugation
is essential to produce platelet deficient plasma specimens because the removal of platelet
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is necessary before the performance of coagulation tests. Centrifugation is time
consuming, and results in impeding the continuous process flow for hemostasis testing.
Manual processes of centrifugation include balancing of tubes, loading them into the
centrifuge, and removal of tubes after completion of centrifugation step. Manual
centrifugation of samples was at 1500 g for five and twenty minutes while automated
centrifuge was set at 3000 g for seven minutes. A comparison of platelet counts between
the manual and automated centrifuges revealed that the automated centrifuges produced
acceptable platelet poor preparation, while the manually centrifuges produced too high
(centrifuge for five minutes) or too low (centrifuge for twenty minutes) of platelet
concentration. The authors noted that turnaround (TAT) did not improve with the
implementation of the automated centrifuge. Although automated centrifuges did not
affect TAT, a reduction of manual processes could lead to a reduction of errors. The
recommendation was to implement automated centrifuges for hemostasis testing for
laboratories that have high throughput to improve the quality and reliability of results
(Sedille-Mostafaie et al., 2013).
Singapore General Hospital (SGH) implemented LAS to decrease cost, reduce
waste, improve turnaround time, minimize manual processes, and simplify staff training
(Lam & Jacob, 2012). There were several expectations from the implementation of the
LAS. The expectation was for the LAS to automate sample processing. The expected
throughput of the LAS was to process more than five million tests annually. Capabilities
of the LAS included sample receipt, sorting, sample prioritizing, centrifugation,
decapping and recapping samples, aliquoting, loading and unloading of samples, and
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transfer of samples to storage. Data collection compared turnaround time, laboratory
errors, and staff satisfaction before and after implementation of LAS. SGH implemented
LAS in 2007. Data compared between June 2007 and April 2008 yielded several
outcomes. Data comparison showed that turnaround time decreased by 30% for stat
samples and 13.4% for routine samples post LAS implementation. In a surprise finding,
there was an increase of laboratory errors post implementation of LAS. A contributing
factor for these errors was the inexperience of staff with the LAS. Collected survey data
for staff satisfaction took place for over a week in March 2008. Staff frustrations
included barcode labeling, inadequate centrifuges to handle workload, and increased
processing time. There was documentation of LAS advantages such as improvements in
turnaround time, laboratory errors, and staff morale, but SGH did not experience these
benefits post LAS implementation. Results indicated that as the staff gained more
experience with the LAS, the advantages of the new system would become apparent.
Data shows a pattern of most preanalytical errors occurring because of mistaken
or mishandled procedures during collecting and handling of blood samples (Lippi &
Plebani, 2012). As a result, poor quality samples are unsuitable for laboratory testing.
Leading the pack of poor quality is hemolysis. Hemolysis causes erroneous results and
recollection to provide the clinicians with reliable results. This causes a delay with
reporting results to the clinicians as well as increased operational costs. Visual inspection
of hemolysis is also unreliable (Hammerling, 2012). Advancement of laboratory
technology provided new and reliable means to eliminate these variables. One solution
was to install liquid level sensors in the instruments to detect low volume and microclots
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or bubbles. Another solution was to implement barcode or radiofrequency identification
technology to allow bidirectional interfacing between the instruments and LIS. Barcodes
are a preventive action to minimize identification and transcriptional errors. Management
of unsuitable samples, especially with hemolysis, remains a major issue even with these
breakthroughs. Traditionally, the degree of hemolysis is the visual comparison of the
color in the tube against standardized color-coded scales. The hemolysis index has the
ability to help phlebotomist, nurses, and laboratory technologists by eliminating visual
inspection before analyzing the specimens (Lippi & Plebani, 2012). This technique
resulted from the ambiguous interpretation of hemolysis in a sample. With newer models
of diagnostic instruments, manufacturers installed a serum indices system that includes
the HI. Hemolysis index has the ability to measure the cell-free hemoglobin in a sample
and report if the sample is suitable for testing. Advantages of HI include eliminating the
arbitrary judgment of visual inspection, transmission of HI to LIS, and assessment of
sample suitability. Limitations of HI include unclear effects on turnaround time, only
assessing sample quality without diagnostic benefits, and not having the capability to
adjust test results.
Barcode identification. The wrong blood transfused to the wrong patient is the
most frequent cause of morbidity in transfusion medicine (Heddle et al., 2012). This
error can result in a hemolytic transfusion reaction and is the second leading cause of
transfusion related death in the United States between 2005 and 2009 (Nuttall et al.,
2013). Wrong transfusion poses a higher risk to the patient than contracting human
immunodeficiency (HIV) or hepatitis C virus (HCV) (Murphy et al., 2012). Transfusion
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errors are preventable if healthcare professionals perform the five stages correctly. The
five stages involved with transfusion medicine are wrist banding the patient, sample
collection, laboratory testing, issuing of blood products, and time of the transfusion.
Laboratories are responsible for sample collection (preanalytical), laboratory testing
(analytical), and issuing of blood products (postanalytical). Sample collection errors
occur when the phlebotomist collects blood from the wrong patient or labels the tube
incorrectly. A root cause analysis revealed that 58% of transfusion errors resulted from
sample collection from the wrong patient and 36% resulted from patient misidentification
(Adibi, Khalesi, Ravaghi, Jafari, & Jeddian, 2012). These two types of errors can cause
ABO incompatibility and may result in hemolytic reaction or even death.
Barcode identification has the potential to mitigate transfusion errors (Nuttle et
al., 2013). This system involves handheld computers to check if patient details on the
wristband barcode match those on the barcode and on the blood bag. A study compared
pre and post implementation of a barcode based blood identification system at Mayo
Clinic, and revealed six transfusion errors with misidentification pre implementation
compared to one misidentification post implementation (Nuttle et al., 2013). The one
incident occurred when scanning of the blood product and patient wristband took place
after starting the transfused unit. A positive identification system such as barcoding
could reduce patient sample and identification errors (Snyder et al., 2012). Errors in
transfusion medicine are avoidable thanks to the evolution of modern technologies such
as the barcode identification system. However, there is a need for systems to monitor
hemolytic episodes worldwide (Adibi et al., 2012; Nuttle et al., 2013). These systems
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collect information on adverse or near miss events in transfusion therapy. Data collected
exposed an increase of near miss transfusion errors after the implementation of the
barcode system (Nuttle et al., 2013). Prior to pre implementation, there was one reported
near miss transfusion errors; whereas, 34 near miss transfusion errors occurred after
implementation.
Summary. Modern technological advancements in laboratory medicine make it
possible for laboratories to meet the demand of increasing test requests while providing
quality performance and timely test results. Laboratory automation has the ability to help
most clinical laboratories profit from integrated preanalytical processes by limiting
specimen handling, preventing mislabeling, and relieving laboratory staff from repetitive
activities such as transporting specimens and loading analyzers (Lippi & Plebani, 2012).
Researches discussed above demonstrated that automation of preanalytical processes is
effective and achievable.
Transition
Section 1 was an introduction to the different elements of the chosen research
topic of preanalytical errors. Areas explored included background of the problem,
problem statement, purpose statement, nature of the study, research questions, the
conceptual framework, assumptions, limitations, delimitations, and significance of the
study. This section also included an extensive discussion of the review of the literature,
which exposed three themes: causes of preanalytical errors, quality management, and
possible preventive
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Discussion for Section 2 will include the justification and rationale of the scope of
the project, the researcher’s role, the chosen method, research design, and strategies for
accessing participants. Section 2will also discuss data collection, organization, and
address issues concerning reliability and validity.
Section 3 will provide an overview of the study, findings from the research, the
applicability of these results to mitigate errors in laboratory medicine, the implications
for social change, recommendations for action and further study, reflections, and study
conclusions.
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Section 2: The Project
The goal of this qualitative case study was to explore the strategies used by
medical laboratory managers to minimize preanalytical laboratory errors. Exploring
these strategies may produced findings to prevent these errors. This research contributed
to the objective of reducing medical errors responsible for thousands of deaths, costing
billions of dollars annually.
This section discussed the purpose of this study, the researcher’s role in collecting
study data, study population, and the use of purposive sampling used to access study
participants. Discussion of the qualitative research method and case study design, data
collection strategy, analysis of data, and reliability and validity of the instruments used
were also discussed in this section.
Purpose Statement
The purpose of this qualitative case study was to explore in depth how medical
laboratory managers reduced laboratory errors in the preanalytical phase. Participants for
this case study were medical laboratory managers in at least two medical laboratories in
southern California who reduced laboratory errors in the preanalytical phase. The
information yielded from the semi-structured interviews provided management and
health care personnel with an avenue to reduce laboratory errors. Preventing the patient
from experiencing detrimental physical or emotional effects caused by laboratory errors
contributed to a positive patient experience. This elicited interest from leaders in health
care sectors as well as patients. Eliminating laboratory errors will improve patient safety,
reduce operational costs, and increase revenue.
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Role of the Researcher
Defining the researcher’s role was important to provide credibility for the
research topic (Unluer, 2012). The researcher’s role was to collect, organize, analyze,
and interpret data a study produces (Mikėnė, Valavičienė, & Gaižauskaitė, 2013). I was
the primary data collection instrument for this quality case study. Experience, training, or
approach of the researcher played a pivotal role on the validity of collected information
(Mikėnė et al., 2013). Data collection for this study included semi-structured, openended interview questions. Open-ended questions encouraged the participants to provide
detailed responses based on their views, opinions, feelings, knowledge, and experiences
(Mikėnė et al., 2013). Following data collection, I transcribed, disseminated, analyzed,
and synthesized the data until meaning emerged. Reporting of results was based on
evidence provided by the participants without the researcher’s bias or viewpoints.
Credibility of the research topic depended on the experience and qualification of
the researcher (Unluer, 2012). As a clinical laboratory scientist for two decades, I was
acquainted with the issue of laboratory errors. Having been a manager of a clinical
laboratory for more than five years, I dealt with this issue, and at times, experienced
frustration at the occurrence of the events. My experience as a quality assurance manager
enabled me to examine laboratory errors through a different lens. Given these
professional experiences, I conducted this qualitative case study from different
viewpoints. Participants consisted of medical managers from at least two organizations.
The rationale for selecting this group of participants was because of their proven ability
to implement processes demonstrating a reduction of preanalytical errors. The
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advantages of choosing within my professional group were my ability to understand the
phenomenon under study, and validate the answers given by participants because of my
knowledge of the field. Being familiar with the topic was a potential drawback because
familiarity might lead to bias and to unconsciously making the wrong assumptions.
The art of a qualitative research was to expose the human part of a story (Jacob &
Furgerson, 2012). Interviews were the primary tools to extract the experience from the
participants. Acquiring the proper interview skills enhanced the interviewer’s ability to
gain insights to the participants’ experience of the subject under study. Having an
interview protocol that elicited participants’ perspectives on their successes with
minimizing preanalytical errors was crucial to the interview. An interview protocol
consisted of a list of interview questions as well as a procedural guide, which included
scripts to direct the researcher through the interview process (Jacob & Furgerson, 2012).
The interview protocol consisted of 10 semi-structured interview questions based on the
literature review. Using the literature review as a guide to develop the interview
questions allowed the researcher to concentrate on questions that produced meaningful
data. This also validated the researcher’s understanding of other scholars’ findings of the
subject.
Prior to collecting data, I obtained the required permissions from the Walden
University Institutional Review Board (IRB). This process ensured that the researcher
followed the protocol for ethical research outlined by the Belmont Report. The United
States Department of Health, Education, and Welfare developed the Belmont Report in
1979 to protect participants in research studies (Greaney et al., 2012). This document
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ensured that participants understood the nature of the experiment, their rights as
participants, and their roles in the experiment. Once the IRB approved my application, I
followed the Belmont Report protocol. This included informing participants of the
consent process, protection afforded to research subjects, and respecting their rights.
Participants
I considered the data source to find evidence to support their explanations as part
of the study design (Sangster-Gormley, 2013). The data source was the interviews
conducted with medical laboratory managers in their real-life context with the primary
goal of exploring their successes with preanalytical errors. I selected at least two health
care organizations with laboratories in southern California. Within these health care
organizations, the selection of potential participants was narrowed to medical laboratory
managers with a minimum of two years of preanalytical experience with success of
minimizing preanalytical errors. Recruiting participants without preexisting relationships
with the researcher enhanced the authenticity of the data collected, as recommended by
Isaac (2014). Purposive sampling aimed to recruit a specific group of participants who
share similar characteristics in relation to the social phenomenon under study (Petty et al.,
2012b). The participants’ experiences provided perspectives to the central research
question, “How do medical laboratory managers reduce laboratory errors in the
preanalytical phase?”
To gain access to potential participants, I used my professional contacts or
LinkedIn to identify the participant pool. I sent a recruitment letter to organizations with
a laboratory in southern California. The recruitment letter (see Appendix A) included a
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formal introduction with my name and credentials, an overview of the study, participant
criterion, and contact information if they chose to participate. To encourage
participation, the letter included assurance of confidentiality and a notice that the results
and consent form would remain in my possession for 5 years. Upon completion of the
recruitment process, I contacted the interested participants via telephone or email to
provide additional information pertaining to the study. Additional information included
the purpose of the study, their role as a participant, and risks and benefits to participate.
Once the potential participant agreed to divulge their experience, I sent a consent form
(see Appendix B) informing participants of the opportunity to take part in a scholarly
study that could provide laboratory management with information to reduce preanalytical
errors. Included in the consent form was the option to refuse participation at any point
during the study without penalty, and disclosure of the lack of incentive for participating
in the study. If the participant decided to withdraw, an email or verbal refusal would stop
the data gathering process. The intent of these correspondences was to establish a
trusting working relationship with the potential participants to elicit honest responses.
Research Method and Design
Research Method
The research question is the driving force behind research methods (Petty et al.,
2012a). Quantitative, qualitative, and mixed methods are the main research methods
used by researchers. Quantitative researchers used deductive reasoning to confirm or
reject the hypothesis (Van Griensven et al., 2014). Qualitative research aims to explore
the phenomenon occurring in its natural setting (Mikėnė et al., 2013). Three fundamental
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characteristics that define qualitative research, as identified by Morse (as cited in Prion &
Adamson, 2014), follow. First, the participants provided the truth and meaning of the
research. Second, this type of research enabledthe researcher to develop a holistic view
of the phenomenon under study based on the participants’ perceptions of values, beliefs,
and experiences. Third, the method of data collection was inductive and interactive. In
other words, a researcher could change the inquiry process as a better understanding of
the phenomena emerged (Prion &Adamson, 2014). The type of collected data defined
the research method (Van Griensven et al., 2014). Data analysis consisted of the use of
statistical tools to analyze the numerical data in quantitative research (Parylo, 2012; Prion
& Adamson, 2014). This method condensed large amounts of data into interpretable
results to test or verify the hypothesis. Data analysis in qualitative research can be time
consuming and tedious. This process involved the synthesis of large amounts of written
data such as interview transcripts, observations of non-verbal communication, drawings,
or film (Van Griensven et al., 2014). Data collection and analysis can occur
simultaneously and interpretation of results could change as new information emerges.
Mixed methods research allows the researcher to conduct a hybrid of qualitative and
quantitative research (Van Griensven et al., 2014). Investigators choose mixed methods
approach to explore a more complete and deeper understanding of the subject under study
by triangulating numerical and textual data. The goal of any chosen method is to provide
results with convincing evidence to answer the research question.
Many researchers used mixed methods to strengthen their findings. Researchers
employ mixed methods when data collected from a qualitative or quantitative approach
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did not produce enough information to explain the research question (Wisdom et al.,
2012). Mixed methods research was not appropriate for this study because semistructured interviews were sufficient to produce a breadth and depth of understanding to
the ability of medical laboratory managers at minimizing preanalytical errors.
Qualitative research is more applicable to answer the research question, “How do
medical laboratory managers reduce laboratory errors in the preanalytical phase?” for
several reasons. First, this study sought to understand the phenomena of laboratory errors
with the views and experiences of medical laboratory managers in their natural settings
(Isaacs, 2014). Second, qualitative research provided a close-up view with a deeper and
richer understanding of the research topic (Cronin, 2014). Third, the inquiry into the
research question was to use inductive reasoning to uncover shared experience by the
participants, and not deductive reasoning to test theories or hypotheses (Harrison, 2013).
Last, qualitative research was superior when attempting to explain or describe the
perceptions of a population using a representative sample (Parylo, 2012). I sought to
understand patterns, similarities, and differences between the participants’ perspectives
through the semi-structured interviews.
Factors indicating the use of quantitative methods included a deductive approach
wherein a theory or hypothesis confirms the purpose statement, study variables, and
research questions (Crede & Borrego, 2014). Several reasons indicated that quantitative
research was not appropriate for this study. One reason is that the design of this study
sought the individual perspective of each participant as opposed to controlling variables
and context (Erlingsson & Brysiewicz, 2013). Another reason was the lack of
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collaboration between the researcher and the participants. Involvement between
participants and researcher in quantitative research is minimal to nonexistent because
data collection is mainly through surveys or experiments (Parylo, 2012). Data collection
in qualitative research involved the researcher interacting with the participants to extract
their experiences with the subject under study. This study did not involve a large number
of participants to project the studying findings onto a larger population, as recommended
by Petty et al. (2012a). Quantitative researchers used statistical procedures to analyze the
collected data (Parylo, 2012). The use of statistical procedure would not provide rich and
vivid descriptions of the collected data. Achieving rich and vivid descriptions in
qualitative research required careful coding, analysis, and interpretation of the semistructured interviews.
The nature of the research problem under investigation, the qualitative method
was a better choice to investigate medical laboratory managers’ strategies to minimize
preanalytical errors. Employing the qualitative research method was a means of finalizing
results and exploring answers to the research question. A qualitative research method
was appropriate for this study because it uncovered the perceptions of participants and
provided detailed information about the complex phenomena. I strove to reach high
standards of truth and credibility, and to achieve completeness in the data by exploring
real-life contexts in which learning took place.
Research Design
Qualitative research uses textual data to recount the participant lived experience
with the research topic (Erlingsson & Brysiewicz 2012). Sampling strategies, data
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collection techniques, and data analysis are similar among the qualitative designs (Prion
& Adamson, 2014). The differentiation is in the expression of the data and in which
perspective the researcher aims to convey. Qualitative designs commonly used by
researchers are phenomenology, ethnography, and case study (Petty et al., 2012b).
The origin of phenomenology design was from Germany at the start of 20th
century (Petty et al., 2012b). Psychology and philosophy are two areas that are
frequently used in this design to conduct research. This design sought to understand the
unique lived experiences of individuals with the emphasis on pure description of the
phenomenon (Erlingsson & Brysiewicz, 2012). A lengthy interview to explore the
individual’s perceptions, perspectives, and understanding of the phenomenon is another
characteristic of this design (Zou et al., 2014). I contemplated adopting phenomenology
design, but it did not align with this study. The primary focus of this study is to
understand medical laboratory managers’ multiple perspectives with reduction of
preanalytical errors in their natural setting, and not individual experience with the
phenomenon.
Ethnography design studies participants in their everyday setting with the intent
of capturing their common behaviors from ordinary activities (Erlingsson & Brysiewicz
2012). This design often requires the researcher to participate in the cultural activities to
describe the group’s culture (Zou et al., 2014). In some instances, the researcher resides
within the participants to develop an understanding of the shared patterns of behavior,
beliefs, and language of the cultural group (Petty et al., 2012b). The tools to collect data
for this design are observation and interview. Ethnography was not feasible for this study
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because I was not going be an active participant in this study and did not have any intent
to live in the natural settings (i.e. hospitals, reference laboratory) to understand medical
laboratory manager’s success with curbing preanalytical errors.
Case study research (CSR) is a qualitative design that focuses on a specific
situation with the aim to investigate every angle of the situation (Cronin, 2014). This
design involves a systematic inquiry and analysis of one or multiple cases to describe the
phenomenon of interest. CSR is a powerful method for participants to recount their reallife experience of the situation and perhaps identify casual links of the experience as
noted by Yin (as cited in Cronin, 2014). CSR has three advantages (Sangster-Gormley,
2013). First, CSR allows researchers to explore and explain complex phenomena in their
natural setting. Second, this design enables researchers to expose the participants’
perceptions of how they contribute and influence the phenomenon. Third, CSR enables
researchers to understand variations in the setting. A well written CSR allows the readers
to analyze the findings and determine its applicability to their experience with the
phenomenon (Taylor, 2013).
Saturation is the point where data collection cannot produce any new or relevant
information (Dworkin, 2012). In qualitative research, data saturation is hard to achieve
because new information is continuously emerging (O'Reilly & Parker, 2012). Data
saturation depends on the richness and depth of collected data to support the research
question (Harland, 2014). There is no actual formula to determine data saturation in
qualitative research. However, the intent of this study was to collect data until new or
relevant information ceases to exist or until the collected data was sufficient to support
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the research question.
I employed a multiple case study design to create an accurate and complete
description of medical laboratory managers’ experience with successful strategies to
minimize preanalytical errors. The phenomenon of preanalytical errors occurs in real-life
laboratory practices every day. Exploring the causative factors of laboratory errors is
difficult because laboratory testing involves many layers of health care professionals.
CSR is applicable to this research topic for three reasons. One, CSR will permit the
exploration of participants’ real-life experiences in their place of employment. Two,
CSR will provide a platform for the researcher to understand the participants’
contribution and influence in the reduction of preanalytical errors. Last, CSR exposes the
multiple layers of health care processes that contribute to preanalytical errors. The
principle reason for choosing a multiple case study is to compare data and their
applicability to multiple settings (De Massis & Kotlar, 2014).
Population and Sampling
Sampling strategy depends on the nature of the study and availability of
participants (O'Reilly & Parker, 2012). Probability and nonprobability are two sampling
strategies used by researchers (Acharya, Prakash, Saxena, & Nigam, 2013). The
definition of a probability strategy is a random process that provides equal opportunities
for individuals to participate in the study. A nonprobability strategy is purposeful, and
not random; where the recruitment of participants depends on inclusion criteria.
Qualitative research usually adopts the nonprobability sampling strategy (Isaacs, 2014).
This multiple case study used the nonprobability purposive sampling strategy to recruit
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participants with the characteristics or shared experience to the phenomenon under study.
The participants for this study were medical laboratory managers from two health care
organizations. The qualified criterion were a minimum of 5 of laboratory experience, at
least two years of management experience with preanalytical processes, completion of at
least one project to minimize preanalytical errors, and worked for an organization in
southern California. Medical laboratory managers were the forefront of their teams and
had a significant role in any process improvement initiatives. The participants provided
insights to the complexity of health care delivery and played a significant role with
collaborative efforts to reduce preanalytical errors across health care disciplines.
Selecting the purposive sampling strategy helped the researcher to focus on a defined
group of participants to gather the richness of participants’ perceptions of the
phenomenon (O'Reilly & Parker, 2012).
The debate of sampling size of qualitative study is ongoing. Sample size depends
on the research question, and a defined formula to determine the sampling size in
qualitative research does not exist (Isaacs, 2014). A sample size of 12-26 participants
might be appropriate in one study, while other studies start out with a smaller sample size
and recruit more participants to achieve data saturation (Isaacs, 2014). The required
number of participants depends on the amount of information necessary to achieve depth
and breadth of the research question. Sampling for this multiple case study involved
medical laboratory managers from two health care settings. The final selection reflected
the medical laboratory managers’ success with preanalytical errors and willingness to
participate in the study. This multiple case study allowed me to analyze data from an
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individual setting while comparing the results across different settings (Massis & Kotlar,
2014).
Ethical Research
Ethical considerations for any research method are the same. In any type of research
involving human subjects, scrutinizing ethical considerations is necessary to ensure the
protection of the subjects (Hoe & Hoare, 2012). In the United States, the Institutional
Review Board plays a pivotal role in protecting human subjects by reviewing certain
ethical issues in research studies (Lidz et al., 2012) and uses the Belmont Report as a
reference when reviewing research involving human subjects (Kim, 2012). Exploitation
of participants is not permissible, and safeguarding respect for each individual is essential
according to the Belmont Report (Greaney et al., 2012). This report posited that
participants must have autonomy, or the ability to make meaningful choices without
limitations. Sufficient protection should be available for those who are unable to act
autonomously. Qualitative research poses minimal risk in medical research, but is not
risk free (Gibson, Benson, & Brand, 2012). Implementation of proper measures, such as
assurance of anonymity and confidentiality, were necessary to protect all participants in
this research.
I followed procedure to seek approval from the IRB prior to the recruitment and
data collection processes. The IRB approved the application to conduct research and
assigned 08-16-16-0293397 to this study. Upon approval from the IRB, I sent an
invitation to organizations with laboratories requesting their participation in this scholarly
study. Each organization received a letter or email outlining the purpose of the study, the
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inclusion criteria, and contact information (see Appendix A). The invitation included an
assurance of anonymity and a guarantee of confidentiality. Incentives with monetary
value or exchange of favors were not permissible in this study. Prior to the face-to-face
interviews, the participants signed a consent form (see Appendix B). The consent form
outlined the option to refuse participation at any point of the study without reprisal. The
participants could withdraw by email or by verbally expressing their intent to discontinue
their participation at any time. Participation was strictly voluntary, and I will destroy all
data collected prior to a participant withdrawing from the study.
Assurance of confidentiality has the potential to encourage organizations or
individuals to participate in this study. To reduce the risks of breeching confidentiality, I
assigned codes for all participants (Damianakis & Woodford, 2012). Coding removed
identifying information to protect anonymity and minimize the possibility of recognition
within the health care industry. I coded the participants as P1, P2, P3, and so on. Data
did not reveal the identity of the organization or participant. To protect the
confidentiality of participants, I will place the collected data and consent forms in a
personal safe deposit box, where it will remain for a minimum of 5 years. Upon the
expiration of the stated timeframe, I will shred the documents or permanently erase the
files through a software program.
Data Collection Instruments
Semi-structured face-to-face interviews in conjunction with nonparticipant
observations were the primary data collection instruments for this qualitative case study.
Qualitative researchers aim to collect human experience through interviews,
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observations, documents, and audiovisual materials (Jacob & Furgerson 2012).
Structured, semi-structured, and unstructured interviews are the three main modes of
interview instruments (Doody & Noonan, 2013). A structured interview requires the
researcher to ask each participant the same set of questions in the same order and the
expected answers are relatively short (Rowley, 2012). The advantage of this technique is
that the yielded data are easier to code, compare, and analyze. Unstructured interviews
often start out with open-ended questions, and the subsequent questions will evolve
depending on responses from participants (Doody & Noonan, 2013). This technique is
useful when the researcher has little knowledge about the topic or the intent is to collect
background data. Semi-structured interviews are a hybrid between structured and
unstructured interviews. The researcher begins with a set of predetermined questions, but
can develop spontaneous questions to seek clarifications. The responses provided by
participants will determine the direction of the questions (Stuckey, 2013). Face-to-face
interviews produce richer breadth and depth (Englander, 2012). Semi-structured
interviews and observations allow the collection of rich data, which are appropriate to
understand medical laboratory managers’ abilities to diminish preanalytical errors in their
natural setting.
Possessing the proper interview skills and protocols enhances the researcher’s
ability to extract the participants’ experience to the phenomena (Jacob & Furgerson,
2012). Before administering the questions to the participants, I refined my interviewing
skills by practicing on a few colleagues. Improving my interviewing skills enabled me to
encourage the participants to elaborate on their perspectives, as well as the details of their
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experience. I also developed an interview protocol, which included list of interview
questions and a scripted dialogue (see Appendix C). The interview protocol provided me
with a tool to conduct the interviews more effectively. The scripted dialogue included a
procedural guide to prompt me on what to say at the beginning and end of the interview.
I provided the participant with an overview and purpose of the study, discussed the
consent form, and answered any questions or concerns the participants had about the
study at the beginning of the interview. The script included my contact information and a
request to perform member checking at the end of the interview.
To affirm that the study was credible, I employed member checking. Member
checking is a quality control process used in qualitative research to ensure that the
collected data is accurate, credible, and valid (Harper & Cole, 2012). The participants
had the opportunity to review their transcripts, which were verbatim audio recording of
the interviews. I sent the transcribed interviews to each participant to verify the
information. This process offered the participants an opportunity to dispute or approve
the interview’s summary of their views, feelings, and experiences. Correction of
identified discrepancies took place prior to data organization and analysis. Member
checking had the potential to convince the audience that the results are reliable, valid, and
credible.
Data Collection Technique
Interviews, observations, drawings or film are among a few data collection
techniques used in qualitative research (Van Griensven et al., 2014). I collected data
through interviews and observations. Interviews are the technique used extensively to
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collect data in qualitative research (Rowley, 2012). An interview is a means for the
researcher to understand the thought process of participants (Stuckey, 2013). The
advantages of interviews include the ability to gain insights from the participants,
allowing participants to tell their own story, enabling the researcher to observe as well as
listen, permitting the participants to explain reasons and give details for their
interpretation of the issue, and allowing researchers to develop complex questions to
explain the phenomenon under study (Doody & Noonan, 2013). The disadvantages of
interviews are the perception of intrusiveness to the participant; they are time consuming
and costly, could provoke strong feelings, and the interview process is susceptible to bias.
Two types of observations are available to the researcher: formal and informal
(Petty et al., 2012b). Formal observation requires the researcher to request and schedule
an observation session to evaluate a predetermined area. Informal observation involves
the spontaneous request to observe random areas. The researcher can also be a
participant or a nonparticipant observer. Participant observation requires the researcher
to actively participate and take part in the observed situation. In nonparticipant
observation, the researcher is only an observer and does not play a role in the situation.
In this study, data was captured during interviews via field notes, audio and video
recording made on an iPhone. An advantage of observation is that it permits a researcher
firsthand experience to a given situation. The disadvantages of observation are that the
presence of the researcher might alter the participants’ behavior and this technique is time
consuming. I adopted the formal nonparticipant observation method using field notes.
The systematic protocol for these semi-structured interviews involved planning
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and conducting the face-to-face interviews. Planning was important to collecting
effective data. Researchers recommended commencing this process with a set of
predetermined open-ended questions that elicited detailed accounts of the participants’
experience with the research topic (Doody & Noonan, 2013). Ten predetermined openended questions were formulated from the literature reviews and focused on the ability of
medical laboratory managers to minimize preanalytical errors. These questions were in
sequential order, but the flexibility of the semi-structured interview allowed the
researcher to ask the questions out of sequence. Conducting the face-to-face semistructured interviews for this multi case study took place at the participants’ places of
employment (Sangster-Gormley, 2013). Trust and rapport provided a platform for the
participants to answer the questions more honestly. The interviews began with a casual
conversation geared toward creating a comfortable and relaxing environment for the
interview. The face-to-face semi-structured interview included asking all participants 10
open-ended questions. However, during or after the inquiry of the 10 questions, the
participants could ask questions for clarification, or ask additional questions to provide
clarity. Each interview took approximately 30 to 45 minutes. Following the formal
interview process, nonparticipant observations of the organizations’ preanalytical
processes took place for duration of 30 to 60 minutes. The observations allowed me to
gain insight into the workflow of preanalytical processes and their contribution to
mitigating errors. I noted all observations and wrote a description of the observed
situation. Transcription of the interviews was verbatim. Participants received a copy of
the transcript and observation notes to review, dispute, and approve. Member checking

105
provided the assurance that the collected information was accurate.
Data Organization Technique
Qualitative research generates large amounts of data (Ward, Furber, Tierney, &
Swallow, 2013), some collected data might be beyond the scope of the study (Ishak &
Bakar, 2012). Case study requires that preparation of the collected information take
place prior to data analysis (De Massis & Kotlar, 2014). Preparation involves data
reduction, data display, data categorization, and data contextualization. Data reduction
condenses and simplifies the collected data for ease of analysis and allows the researcher
to focus on the evidence that could answer the research question (De Massis & Kotlar,
2014). One tool used by researchers to organize and arrange the data for ease of retrieval
is data display. Dissecting and grouping of information into different categories for
comparisons is data categorization. Data contextualization is comprised of assembling
the data and identifying links and connections (De Massis & Kotlar, 2014). Preparation
of data for this multiple case study involved all of the steps listed above. Data reduction
removed all data that was beyond the scope of this study. Displayed data included data
coding, which allowed me to mark and note information that have had similar themes. I
used data categorization and contextualization to disassemble and assemble the
information to search for relationships in the collected data.
Use of a database to organize the data can improve the reliability of the study
(Baxter & Jacks, 2008). Microsoft Excel was the database employed to organize the
collected data. This software has the ability to manage and organize data, is easy to use,
and is cost effective (Watkins, 2012). I created a workbook containing spreadsheets
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using Microsoft Excel to categorize all information pertaining to this study. This
workbook included a list of potential participants, the receipt of their willingness to
participate, the signed and dated consent form, and the schedule and location for the
semi-structured interviews. The workbook also stored the verbatim transcription of the
audio recordings. Prior to transcribing the data, as suggested by Rowley (2012), I
listened to the recordings and took notes on the significant points that emerged from the
interviews. Transcription of all semi-structured interviews and observation notes
occurred within seven days to preserve the integrity of recorded data. The laptop used to
house the data was password protected and encrypted to assure the security of the data. I
also used Dropbox to retain data as a backup for unpredicted circumstances, which might
erase the data from the laptop.
Removal of participant identity by coding assured anonymity and confidentiality
of the study participants (Marais, 2012). Participant codes such as P1, P2, and P3 were
the assignment for each participant. The designated coding, where P represents the
participant and the numerical number represents the number of interviewees, removed
any discriminating identity and protected the confidentiality of the participants as
recommended by Lam and O’Higgins (2012). The data management plan provides that I
will keep all hard copies such as audio recordings, observations notes, and consent forms
in my personal safe deposit box. The Microsoft Excel workbook will remain in its
electronic form on my laptop and Dropbox account for a minimum of 5 years. Upon the
expiration of the required timeframe, all hard copies will be destroyed through a shredder
or through a software program that erases files permanently.
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Data Analysis
A systematic approach is necessary in qualitative data analysis (De Massis &
Kotlar, 2014). Equally important is to outline the data analysis process to provide clear
and a detailed explanation of the data analysis method to strengthen the study. The
researcher must provide vivid descriptions of how the collected data emerged into valid
findings from the study. Data will require the aid of a qualitative data analysis software
(QDAS) program to produce themes. The three most popular QDASs on the market are
Atlas.ti, MAXQDA, and NVivo (Humble, 2012). All three programs have capabilities to
build theories and allow the import of textual, video, and audio data into the programs.
These programs enable the researcher to engage in open coding and have the ability to
diagram theoretical models. The program chosen for data analysis in this study was
NVivo. The three programs are very similar and the rationale for choosing NVivo was
cost. I have the program in my possession and NVivo has the capabilities that I need to
complete the data analysis process.
I transported the transcribed interviews and observation notes into NVivo to
initiate the data analysis process. This software helps researchers to systematically code
and organizes their data (De Massis & Kotlar, 2014). NVivo can also facilitate data
analysis by identifying themes, providing insights, and reveal relationships between the
different concepts. This step was to sort the collected data into codes and themes.
Information analysis could expose patterns and relationships between the cases to explain
the research question.
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NVivo is the best program to aid data analysis; however, the criticism with the
program is bias (Sotiriadou et al., 2014). This program requires the researcher to develop
a list of codes and rules as an attachment to the data. To alleviate the risk of bias, I will
triangulate the data. Triangulation is the use of more than one approach to explain the
research results (Wilson, 2014). This strategy can increase the confidence and validity of
the findings (Yin, 2013) by providing richer and fuller data (Wilson, 2014). The four
types of triangulation used in case studies are data triangulation, analyst triangulation,
theory perspective triangulation, and methods triangulation. Data triangulation involves
the collection of different data sources. The collection of data can be from different
times, different locations, and different focal groups. Investigator triangulation involves
more than one investigator in the data collection and analysis processes. Theory
triangulation is comparing different theories with the goal to develop knowledge.
Method triangulation uses multiple methods to explain the phenomena (Wilson, 2014).
The data triangulation I used to explain the research question included data from the
semi-structured interviews and nonparticipant observation notes.
Further data analysis, using within case and cross case analyses, will remove any
lingering questions of bias. The first step is to perform a within case analysis to
understand the conditions of the individual cases (Yin, 2013). This analysis could reveal
factors contributing to the successes of the medical laboratory managers’ successes with
preanalytical errors. Next, conducting a cross case analysis could compare the
differences and similarities between the cases. Cross case analysis could assist with an
understanding of how each organization changed their internal processes to reduce
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preanalytical errors. The objective of data analysis in CSR is to analyze all combined
data sources and evaluate their applicability across different settings (Sangster-Gormley,
2013).
The research question, interview questions, and conceptual framework guided the
data analysis process. Concentrating on these elements to conduct data analysis will
prevent the researcher from analyzing data beyond the scope of the study (SangsterGormley, 2013). Selection of key characteristics of preanalytical errors to include in the
interview protocol relied largely on the literature review. I compared the collected data
to the research question, “How do medical laboratory managers reduce laboratory errors
in the preanalytical phase?” and its connection to the conceptual framework of total
quality management. The primary theme for this study was to expose medical laboratory
managers’ ability to reduce preanalytical errors. I searched for the participants’ adoption
and application of the framework to their internal processes in their quest to mitigate
these errors.
Reliability and Validity
Qualitative researchers accept the variations of people’s perceptions to the
phenomena under study and that replicating the results is hard to achieve (Petty et al.,
2012b). The tenets for rigor or trustworthiness in qualitative studies are credibility,
transferability, dependability, and confirmability (Prion &Adamson, 2014). Credibility
refers to the authenticity of the collected data (Houghton et al., 2013). Transferability is
the ability to apply the study to another similar situation. Dependability is a strategy to
assess the stability and consistency of data inquiry (Boesch, Schwainger, Weber, &
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Scholz, 2013). Confirmability is the accuracy of the findings in relation to the enquiry
process and not based on the researcher’s biases (Petty et al., 2012b). Dependability
defends the reliability of the qualitative study while credibility, confirmability, and
transferability justify the validity of the study.
Strategies that this CSR employed were member checking, audit trail,
triangulation, prolonged engagement, prolonged observation, and peer debriefing to
prove credibility, transferability, dependability, and confirmability. Qualitative
researchers use member checking to strengthen the accuracy, credibility, and validity of
the study (Harper & Cole, 2012). Member checking provides the participants an
opportunity to review their transcribed interviews and data analysis for the assurance that
the recorded data are accurate and properly presented (Houghton et al., 2013).
Triangulation is collecting and comparing data from multiple sources to gain meaningful
views of the phenomenon (Cope, 2014). Audit trail includes detailed accounts of
researchers’ decisions and assumptions of the collected information. Prolonged
engagement builds trusting working relationships with the participants to harvest rich and
detailed responses. Prolonged observations of the participants’ emotions and their
responses during data collection would provide the depth of the study. Peer debriefing is
a strategy that engages a colleague with similar experience to help code the collected data
and validate the interpretations (Houghton et al., 2013).
Reliability
Reliability is the ability for the instrument to reproduce the same or similar
outcome repeatedly (Boesch et al., 2013). The selected instrument for this CSR is the
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semi-structured interview protocol containing predefined questions. A predefined set of
interview questions provides a reliable instrument for data collection. The goal of these
interview questions was to allow the participants to reflect on their experience in similar
manner and provide consistent responses attesting to their successes with curbing
preanalytical errors.
Dependability in qualitative research is synonymous to reliability in quantitative
research (Houghton et al., 2013). Dependability is a strategy that qualitative researchers
use to assess the stability and consistency of data inquiry (Boesch et al., 2013).
Qualitative researchers use audit trail to defend the dependability of their study. Audit
trail is a systematic approach qualitative researchers use to demonstrate that the data
inquiry procedure is stable and consistent (Houghton et al., 2013). Audit trail could also
provide traceability of changes made throughout the data inquiry process. Accepting that
data inquiry processes in this CSR are fluid and difficult to replicate (Petty et al., 2012b),
I will use an audit trail to defend all decisions made pertaining to participant recruitment
and selection, interview protocol, data collection, and data analysis.
Validity
The outcome of a concept that the researcher determines to measure is known as
validity (De Massis & Kotlar, 2014). Achieving validity for this CSR was completed
through credibility, transferability, and confirmability. Verification of validity provides
the reader the confidence that findings in this CSR are authentic and without biased
views.
Establishing credibility for this CSR included using strategies such as prolonged
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engagement, prolonged observation, peer debriefing, triangulation, member checking,
and data saturation. Prolonged engagement requires the researcher to spend sufficient
time with the participants to build trusting working relationships (Cope, 2014). To
establish trust, I provided my credentials and ensured participants that all divulged
information would remain confidential. This strategy promoted honest responses from
the respondents without fear of exposure. Prolonged observations of the participants’
demeanors during the interview and the organization processes allowed the researcher the
opportunity to understand the phenomena under study per Houghton et al. (2013). I spent
sufficient time at each organization to understand their successes with reducing
preanalytical errors. Peer debriefing involved enlisting a colleague with similar
background to provide insights to my interpretation of the data as recommended by Petty
et al. (2012b). This strategy validated that my interpretations were correct and without
bias. Data triangulation and member checking can provide credibility by validating that
the analyzed data were accurate. Data triangulation from the semi-structured interviews
and onsite observations proved similar findings regardless of data collection techniques.
For member checking, I asked the participants to review the transcribed interviews and
analyzed data to reflect on his or her experience with reducing preanalytical errors. To
solidify credibility, I continued to collect data until attainment of data saturation. Data
collection surpassed the goal of at least two organizations unless there was a lack of new
emerging data (Houghton et al., 2013). Data saturation indicated a thorough performance
with data collection and analysis.
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Qualitative researchers do not aim to generalize their findings, but to allow the
readers to determine the transferability of the data to other settings or contexts (Petty et
al., 2012b). Transferability relies solely on the researcher’s ability to provide rich and
thick descriptions of the phenomenon under study (Erlingsson & Brysiewicz 2012).
Delivering detailed information allowed the reader to gain proper understanding and
determine if the study was applicable to their setting. Inclusion of appropriate quotations
could boost transferability as suggested by Graneheim and Lundman (as cited in
Houghton et al., 2013). To achieve transferability in this CSR, I provided dense
descriptions of the context, participants, research method, and raw data, and presented the
data with transparency.
Transition and Summary
Section 2 outlined the execution plan for this CSR. The section started with the
purpose of the study and delved into the role of the researcher. Included in this section
were the recruitment and inclusion criteria of the participants as well as the protections
provided to the participants. A rationale for selecting CSR as research method and
design was also included here. Other areas discussed in this section were data collection,
data organization, and data analysis. The section ends with a discussion of reliability and
validity strategies of this qualitative research. Section 3 will present the findings of the
study as well as applications to professional practice, implications for social change,
recommendation for action and further study, and study conclusions.
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Section 3: Application to Professional Practice and Implications for Change
Introduction
The third and final section of the research study is the application of the findings
to professional practice and the implications for change. The purpose of this qualitative
multiple case study was to explore in-depth how medical laboratory managers reduce
laboratory errors in the preanalytical phase. Participants for this case study were five
medical laboratory managers from two medical laboratories in southern California who
successfully reduced laboratory errors in the preanalytical phase. These medical
laboratory managers have at least five years of laboratory experience; two of those years
spent managing the preanalytical area and successfully completing one project to
minimize preanalytical errors. These individuals are leaders within the laboratory
industry with knowledge of minimizing preanalytical errors. A qualitative thematic
analysis was the approach performed to analyze the interviews for this multiple case
study. NVivo 11 by QSR was also employed to systematically code the responses of the
managers in the interviews and form the themes addressing the research question of the
study. The central research question that guided the study was: How do medical
laboratory managers reduce laboratory errors in the preanalytical phase? This section
also includes the following: Presentation of Findings, Applications to Professional
Practice, Implications for Social Change, Recommendations for Action,
Recommendation for Further Research, Reflections, and Conclusion.
Presentation of the Findings
I will present the outcome of the interviews through qualitative thematic analysis.
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Seven hospitals with medical laboratories received the invitation to participate and two
agreed to partake in this study.

The two organizations received and signed the letter of

consent prior to the interview process. Company A had two participants while three
participants participated in the study from Company B. I scheduled the interviews at the
participants’ place of employment and conducted semistructured interviews to gain an indepth understanding of strategies the medical laboratory managers used to minimize
preanalytical errors. Each participant answered the 10 open-ended interview questions,
and the purpose was to collect the respondents’ practical experience in reducing
preanalytical errors and to answer the main research question: How do medical laboratory
managers reduce laboratory errors in the preanalytical phase? Participants spent no more
than an hour reviewing and answering the interview questions. I spent an additional hour
at each facility observing their preanalytical processes and captured the data through
observational notes. Assignment of P1, P2, P3, P4, and P5 as aliases provided
participants with identity protection. Transcription of the interviews took place within
seven days after the interview. The participants received the verbatim transcripts to
verify the accuracy of the information. This member checking process also allowed the
participant an opportunity to refute or add additional information. Data analysis involved
entering the transcribed data into NVivo 11 qualitative data analysis software. This
software coded the data and exposed themes from the participants’ responses. Five
themes emerged within and cross case analyses: quality improvement, recognition,
reward, and empowerment, education and training, communication, and patient
satisfaction.
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Case One: Company A
The first case was Company A where P1 and P2 provided interviews. In
Company A, both managers emphasized the company’s main priority of providing high
quality of care and service. Table 1 contains the breakdown of themes for Company A.
Table 1
Breakdown of Themes for Company A
Thematic Label
Themes and Sub-Themes
TL 1. Identifying the cause of Monitoring and measuring
the laboratory errors in the
of quality indicators
preanalytical phase
Diagnosing the root cause
of the problem
• Reviewing each
case using
documentation,
observation, and
interviews
Processing of specimens
• Ensuring the
integrity using a
specimen form
TL2. Identifying and
Strengthening the skills
implementing the solutions
and organizational
and interventions in reducing
involvement of staff
laboratory errors in the
members
preanalytical phase
• Training staff
members
accordingly
• Praising and
motivating of staff
members
• Assessing the work
of staff members
• Practicing of open
communication
Revising the Standard
Operating Procedure or
SOP as needed

Number of Occurrences
1
1

1

2
2
2
2
2
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TL3. Identifying the effects of
reducing laboratory errors in
the preanalytical phase

Monitoring problems
through meetings on a
regular basis
Engaging members of the
management in ensuring
quality of service in their
practice and culture
Systematically encoding of
data
Avoiding loss in revenue
from errors
• Improving
customers’
impressions of the
laboratory
• Not needing to
repeat laboratory
tests due to errors
• Providing
customers with
better and quality
care

2
1

1

2

2
1

Case Two: Company B
The second case of the study is Company B, where three managers, P3, P4, P5,
participated. Again, all managers expressed the need to provide quality service. Table 2
contains the breakdown of themes for Company B.
Table 2
Breakdown of Themes for Company B
Thematic Label
Themes and Sub-Themes
TL 1. Identifying the cause of Re-assessing the policies
the laboratory errors in the
and performance of staff
preanalytical phase
members
• Examining the
productivity and
service of
employees

Number of Occurrences

2
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Examining the
policies of the
company
Diagnosing the root cause
of the problem
• Reviewing the
feedback of staff
• Performing a root
cause analysis
Processing of specimens
• Using specimens
and documentation
to look for the
pattern of error
Strengthening the skills and
organizational involvement
of staff members
• Practicing of open
communication
• Educating staff
members about the
policies and
regulations
• Monitoring and
assessing the work
of staff members
• Training of staff
members in
correcting the errors
• Recognizing and
rewarding staff
members
Engaging members of the
management in ensuring
quality of service in their
practice and culture
Implementing a test of
change
Implementing a corrective
action plan
Monitoring of problems
through meetings on a
regular basis
•

TL2. Identifying and
implementing the solutions
and interventions in reducing
laboratory errors in the
preanalytical phase

1

1
1
1

2
2

2
2
2

3

2
1
1
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TL3. Identifying the effects of
reducing laboratory errors in
the preanalytical phase

Practicing constant
documentation
Avoiding the loss in
revenue from the errors
• Providing
customers with
better and quality
care
• Improving
customers’
impressions of the
laboratory
• Not needing to
repeat laboratory
tests due to errors
Practicing preventive
measures benefitting their
customers

1

2
2

2

1

Theme 1: Quality improvement. Quality affects the individual’s decision to
choose a health care provider (Santos, Gravelle, & Propper, 2016). Patients are more
likely to choose practices with highly published quality. The participants in this study
also expressed this sentiment. In the within and cross analyses, all participants agreed
that quality is their primary concern when delivering laboratory services. Quality is the
cornerstone of medical laboratory services because it can reduce laboratory errors,
improve patient experience, and decrease operational costs. These errors can increase
operational costs because investigation and rework requires additional resources (Carlson
et al., 2012).
In Company A, P1 and P2 emphasized that their company’s main priority is to
provide quality of care and service. Participants in Company B explained that quality is
the focal point of their service because poor quality equates negative patient experience.
P5 explained that improving quality could prevent rework, and P4 reiterated that
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improving quality could decrease operational cost with a reduction of errors. P1 and P2
also expressed concern over the loss of revenue because of laboratory errors. P1
indicated, “The lab can’t bill for the canceled tests means losing revenue. The lab also
spends time in investigating the errors, which causes cost. The physicians not obtaining
the lab reports on time causes them to seek for another lab.” P2 concluded that by
reducing errors, they are saving the resources and identified that rework affects the
company negatively. By improving their process and system, errors are reduced leading
to decreased operational cost. P4 shared that a reduction of preanalytical errors should
have a domino effect to the company. By providing quality of care, the company could
benefit from decreased operational cost, improved patient experience, and thus, gain
competitive advantage by offering cheaper prices for their service with better customer
experience. P5 asserted that Company B is constantly working to improve quality. She
acknowledged that there are many options of healthcare available to consumers and
providing quality affordable healthcare is a strategy the company uses to increase and
retain their market share.
The two cases use similar quality improvement tools to assess, measure, and
prevent errors from occurring or recurring. Tools used to focus on quality are QIs, root
cause analysis, and preventive measures. QIs are primary tools allowing users to
measure and monitor quality improvement by comparing it against defined criterion
(Plebani et al., 2013b). Root cause analysis could expose possible errors and identify
weaknesses in the system that allowed these failures to occur (Reid & Smyth-Renshaw,
2012).
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Quality indicators (QIs). Researchers proved that the development and
implementation of quality indicators and quality specifications for effective management
of procedures contributed to a decreased rate of errors (Plebani et al., 2014a). Another
group of researchers proved that a reduction of preanalytical errors resulted after the
completion of training on QIs (Agarwal et al., 2012). Companies should implement QIs
to monitor and assess their processes for possible errors (Majkić-Singh & Šumarac,
2012). P1 indicated that the company uses quality indicators to monitor laboratory
errors. He asserted that the indicators allow them to focus and fix the areas that need
improvement. P1 stated, “We have about 10 different QA indicators that we monitor on
a monthly basis. When any one area is above our threshold or unusually high, we focus
on that particular area.” P2 also explained that the company monitors and discusses
quality metrics with the QA department on a consistent basis. P5 explained that their
company also tracks quality assurance parameters and addresses any anomaly. By
identifying and monitoring the errors, laboratories can implement appropriate process
improvement to enhance patient experience. Evidence based approaches require
laboratories to closely monitor their processes, implement a system to detect errors, and
perform root cause analysis when the same error occurs frequently (Plebani et al., 2015).
Root cause analysis. Root cause analysis is a systematic approach to exposing the
causes of the errors (Reid & Smyth-Renshaw, 2012). P3 asserted that when an error
surfaces, she reviews the workflow to determine the cause of the problem. Reviewing the
workflow might expose the problem as personal or systematic. P3 said, “Like I said, is it
the system or personnel issue? Then I reviewed the broad picture to see what is the
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general outcome and then from broad picture to the minute detail and everything has to
be documented and who knows what we will get from that documentation.” P5 stated
that before she can diagnose the problem, she needs to “understand the workflow, work
process, I would need to understand everybody’s piece.” P4 added that conducting a root
cause analysis is effective and gave the five why’s as an example of examining and
diagnosing the problem. She stated, “So, you do a root cause analysis and we would also
do, for example, the 5 Whys.”
P1 explained that they examine each case carefully to determine the root cause of
the error or the issue. He furthered stated that the main methods used were examining
documentations, interviewing the staff, and observing them as they complete their tasks.
He stated, “We diagnose the root cause of the problem by back-tracking each case,
reviewing documentation, interviewing staff, and observing while they perform the task.”
Another practice to perform root cause analysis at company A is to document issues or
problems on the Specimen Integrity Form. P2 said that when processing samples, the
processor uses the Specimen Integrity Form to search for issues or problems within the
system. Using the Specimen Integrity Form can help the organization diagnose the
problem by identifying the type and location of errors. P2 insisted, “As we are
processing the specimens coming from the clients or the patient service center, we are
able find out any problems with the specimens at that time.”
Preventive measures. Patients can benefit when companies practice preventive
measures. P3 believed that by practicing the preventive measures, their company
increases the safety and quality of service provided to their customers. She stated, “A
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good quality process maintains stability as in forecasting future errors and prevents them
from happening. Therefore, Company B, we are big in preventing, preventive
maintenance. I see quality as a preventive maintenance. We prevent bigger errors from
occurring. Therefore, the outcomes are beneficial to our customers, which is valuing
their health.”
Identifying patterns of error is another preventive measure that both companies
use. Company B spent much time and effort to determine the patterns and faults within
their system. P4 stated, “Usually, in the laboratory, we do collect specimen processing
errors and then from the data collected, look for common errors, patterns, or anything we
could find.” P2 explained that they use a spreadsheet to record the errors. The QA
committee discusses and identifies all problem areas. By categorizing these errors, the
company can identify which type of errors occurred more frequently, and then implement
preventive and corrective actions to mitigate these errors. Another practice used by the
managers at Company A was to monitor the problems through their regular meetings. P1
shared that they constantly and regularly monitor the issues in their area to ensure that
they are performing and providing service effectively to their patients or clients. He
stated, “We continue to monitor the problem area on a monthly basis to ensure its
effectiveness.” P2 added that they monitor their policies and SOPs through their regular
meetings. The meetings are a mechanism to ensure correction of the issues and enforce
training. P1 stated that one of the preventive measures implemented was revising their
SOP. He stated, “We revise our SOP and train our staff accordingly.” Company B also
said that the most significant processes of identifying the cause of laboratory errors is
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through the reassessment of the policies. P3 explained that they reassess their policies
once issues arise. They test to see whether their policies are in line with their practices. If
there are misalignments, they modify their policies and regulations.
Theme 2: Employee reward, recognition, and engagement. A direct
correlation can be seen between accomplishing organizational tasks with employee
reward, recognition, and engagement (Manzoor, 2012). P5 explained that motivation and
energizing staff is really hard. Methods used to overcome these obstacles are through
employee reward, recognition, and engagement programs. The literature review did not
reveal these two strategies as ways to improve quality.
Employee reward and recognition. Organizations that adopt recognition by
displaying appreciation and allowing their employees to participate in the decision
making process experienced an increase in job satisfaction, thus stimulating the
employees to work towards a common goal (Manzoor, 2012). P1 highlighted that they
give great importance to their personnel by increasing their involvement and motivation
to perform well for the company through commendations and small tokens as rewards for
positive service: “We praise personnel on areas that they do well in and give them small
tokens in doing so.” P2 confirmed that they have incentive and recognition programs to
increase the motivation of the staff members in performing beyond their assigned tasks
and responsibilities. She stated, “We do have an employee incentive and recognition
program that we have just implemented to employees that have improved and have gone
above and beyond their job description.” P4 explained that they value their staff
members and one way to show this appreciation is through rewards and recognition
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programs. Employees receive rewards and recognition when the department achieves
quality goals.
Employee engagement. The definition of employee engagement is the
involvement and commitment of employees towards the organization and its values
(Anitha, 2014). Engaged employees are more responsible towards business goals,
promote teamwork, and go above and beyond to perform their job. Organizations that
embrace employee engagement gained competitive advantage. P1 explained that
engaging staff ensures the practice of quality service and performance at all times. P1
said that the organization involves all team members in the pursuit of quality service. He
stated, “It starts from the top – from the owners of the laboratory to the middle
management and trickling down by engaging quality into our daily practice and culture.”
P3 emphasized that she constantly engages employees in the company’s quest to provide
their customers with a quality and safe healthcare service. P4 furthered that they
combine efforts with the rest of the staff to ensure that the whole company and its system
has one goal, which is to provide the best care for their customers. P5 emphasized the
company’s value for teamwork and collaboration. She believes that through teamwork,
they are better equipped with the ability to provide the best service to their customers. P5
acknowledged that employee engagement is a difficult task. In order to implement a
strategy successfully, medical laboratory mangers need to engage their staff. This is
because they are the frontline workers who have a comprehensive understanding of each
process. When engaging staff in root cause analysis or process improvement, it is
important to remember each idea or opinion is equally important. Working

126
collaboratively with the staff will produce better outcomes than dictating to them what to
do. P3 noted the importance of involving staff members in the root cause analysis. She
shared that the examination should start with the collection of feedback from staff
members to better identify the causes of the problems experienced. P5 alluded to the
importance of teamwork within the company. She emphasized that her staff’s
involvement is crucial in order to make them feel empowered and important parts of the
company and ensure the effectiveness of the process change. P3 shared that it is also
important for them to gather feedback from their staff based on their firsthand
experiences in order to promote and provide better quality of service to their customers.
P3 stated that as a manager, she ensures that all employees are engaged within the system
changes of the laboratory and organization. She explained that the buy-in and
involvement of the members are significant to correcting the errors and issues present in
their laboratory. P1 discussed that they also observe and review the work of staff
members for feedback and constant improvement of their work. He stated, “Do more
direct observation and review their work.” P2 explained that the involvement of staff
members in the development of a QA system to correct the issues is needed by saying,
“Again, we focus on the training. We have communication throughout the laboratory.
Also, we do get the employees involved in the QA management system so they can see
where we are lacking and which department.”
Theme 3: Training and education. The third major theme discovered was the
strengthening of skills and organizational involvement of the staff members.
Organizations rely on their workforce to be successful because workforce is the biggest
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asset to any organization. An organizations’ ability to thrive and survive depends on the
efficient performance of employees (Tahir, Yousafzai, Jan, & Hashim, 2014). To
optimize the performance of employees, organizations should implement training and
education programs. These programs can contribute to the overall goal of the
organization and benefit the organization as well as the individual. With the acquired
knowledge and skills, trained employees are more efficient and can perform their job
competently. Continuous training and education of employees could improve their job
performance (Amin, Rashid Saeed, & Lodhi, 2013). These programs provide
opportunities for employees to learn current and future skills. Organizations that invest
in training and development enjoy increased productivity and a high return on
investment.
Although two studies disputed that training and education can improve
preanalytical errors (Bölenius et al., 2013; Romero et al., 2012), participants in this study
repeatedly stated that they adopted training and education as ways to improve quality.
Both cases indicated that training was crucial to reducing and preventing errors. P1
added that they train their staff to reduce the probability of laboratory errors and equip
them with the knowledge and ability to manage the issues accordingly. He stated, “We
revise our SOP and train our staff accordingly. By continuously enforcing quality,
providing education, and assessing staff’s competency. Also by assessing staff’s
capabilities; assigning tasks that they excel in.” P2 echoed P1’s response that their
system involves a strict training for their employees by requiring them to attend various
training programs. The trainings involved specimen processing, detecting problems and
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issues accordingly. P2 described other training programs that they implement and require
their personnel to complete; exposing their staff members to a more extensive training by
rotating and assigning them in different departments aided in reducing the future
preanalytical errors. P3 found it important to educate the staff in terms of their policies
and regulations. By doing so, staff members are aware and knowledgeable of the goals,
as well as the changes being implemented in their system. P5 explained that they always
make sure to involve their staff members and give them the opportunity to learn both
independently and with the guidance of the company. Their education of staff members
involves the policies as well as training in their skills required by their job descriptions.
P3 explained that they have a great understanding that their staff members have different
methods of learning. P5 echoed that they have formal and informal staff trainings. P5
said that the education of staff members involves communication and training in
improving their skills to achieve the company’s overall goals. P5 reiterated that when a
staff makes an error, she wants to teach by training and education. She believes that most
mistakes are due to system and not intentional. P5 explains that these methods can help
them understand the root cause of the problem and that they will stride to improve their
performance. She stated, “You know, whatever it is, I feel like we should just, you know,
make sure we study exactly what it is that they are doing, talk them through it, let them
understand where we are coming from. So, I feel like through that it’s more of a personal
approach and I’m not just calling and say hey, you did this error, figure it out yourself,
how you won’t repeat this error in the future. So, that’s a big thing, we would like to
approach it from a teaching standpoint.”
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Theme 4: Communication. Communication is key for ancillary healthcare
teams to improve medical error health care deliverance (Brock et al., 2013). Effective
communication has the potential to improve quality and safety. Specifically, internal
communication has potential to build a culture of transparency between management and
employees (Mishra, Boynton, & Mishra, 2014). The literature review did not find
communication as a strategy to mitigate errors, but cross analysis repeatedly exposed the
use of this strategy. P1 explained that to ensure the involvement and commitment of staff
members, management listens to the needs of their staff members or personnel. The
communication system in place involves personnel on a constant basis with process
improvement. P1 reemphasized the problem areas and the interventions during their
monthly meetings. P5 mentioned that communication is ongoing in order to ensure that
all staff are hearing the same message and are on the same page. Communication is done
in the form of rounding, huddles, department meetings, and groups that work on process
improvement projects. P4 explained that they would discuss and review quality findings
pertinent to laboratory operations. She said that they develop the action plans to address
the presence of preanalytical errors through their constant and regular meetings. In their
meetings, they set their goals and ensure that these are conveyed to the rest of the staff
members. P2 said, “We do review the errors with them that they are making… We have
meetings, and reviews are done annually so employees can see how they are improving
or what they need to improve on.” P3 said, “[It] is very important that we listen to our
frontline.”
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Theme 5: Patient satisfaction. The definition of patient satisfaction is the
agreement between patient expectation of care and the received care (Al-Abri & AlBalushi, 2014). A patient satisfaction survey is a tool used to assess the quality of health
care delivery. P2 explained that patient satisfaction is of utmost importance for the
medical laboratory to retain their patients. When a patient walks into a patient service
center to have their blood drawn, the phlebotomist’s job is to focus on that particular
person and provide the best service. This practice was observed at Company A and
Company B. Both companies practiced customer service by greeting the patients on
arrival. When the patient was called, the phlebotomists introduced themselves and
asked the patient for identification. Each phlebotomist concentrated on their patient
until the completion of phlebotomy.
Laboratory errors could lead to dissatisfied patients. P4 indicated that patient
satisfaction could increase by minimizing errors. P1 posited that errors can cause
patients’ dissatisfaction and decrease confidence in the medical laboratory. If errors are
not minimized, medical laboratories will lose patients, and physicians will seek other
competitors that could provide better care experience. Any negative experience will
decrease a return visit from the patient. P5 indicated that they do not want their
customers dissatisfied with their service; through reduction of errors, customers’
experiences should improve as well. P1 discussed how the reduction of laboratory errors
could lead to customer satisfaction and avoid a negative review and impression of their
laboratory. He stated, “Errors cause unnecessary cancelation of tests, which causes
patients having to come back for a redraw. That leaves patients with a bad impression or

131
confidence of the lab.” P2 added that the reduction of error leads to customers being
satisfied and happy with the services as well as their overall perception of the company.
P1 explained that the reduction of errors also implies that customers are provided with a
better service and quality care. He stated, “By eliminating errors, it will improve
operational costs, give patients and physicians a better care experience, and advantage
over other labs.” P5 echoed that they also reassess the errors based on the customer
service. She explained that customer service is one of the main targets and priorities of
their company and any rework will increase the operational cost. Medical laboratory
managers in Company A and B noted that quality care could improve customers’
impression of the laboratory.
Findings related to TQM theory. The development of TQM occurred post
World War II in an effort to improve productivity and the quality of life in Japan (Powell,
1995). This philosophy aims to improve quality in all aspects within a company and
requires the collaborative efforts of the entire organization (Gimenez-Espin, JiménezJiménez & Martínez-Costa, 2013). Components of TQM provide medical laboratory
managers with a systematic approach to quality improvements. Implementing TQM
allows laboratories to reduce process variations, eliminate waste, minimize errors, and
improve operational costs. TQM is an important mechanism to promote effective
operation while attaining competitive advantage. Influential aspects that contribute to the
success of TQM are leadership, organizational skills and culture, management
commitment, and empowerment (Powell, 1995).
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TQM is applicable to this study through accreditation agencies such as ISO
15189. This accreditation agency, and others, defined a set of standards that medical
laboratories must adhere to in order to obtain or retain their accreditation. ISO 15189 is
an internationally recognized agency specifically regulating medical laboratories in
demonstrating their ability to provide quality laboratory services (Serteser et al., 2012).
Quality management is the element that is outlined by TQM and it correlates with the
standards of ISO 15189. The medical laboratory managers in this study also
demonstrated the importance of quality management.
The central focus of TQM is meeting or exceeding customer satisfaction and it
requires that the organization produce quality service. International Organization for
Standardization 15189 outlined the importance of meeting this requirement. It requires
organizations to have processes in place to monitor the quality service. Organizations
need to monitor quality service through client complaints and defects. Regular meetings
must occur to address client complaints and defects and to determine the root cause of the
problem in order to develop appropriate corrective and preventive actions to meet
customer satisfaction.
Company A and Company B assess their quality through department meetings,
huddles, and with the QA departments on a consistent basis. This assessment includes
the review of client complaints, quality indicators, and any necessary changes needed to
improve quality. Part of the assessment is to discuss the root cause of the error and allow
them to develop preventive and correction actions. Company A and B use root cause
analysis (RCA) to diagnose errors. RCA is a methodological approach to investigate the
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cause of the problem (Reid & Smyth-Renshaw, 2012). This approach looks beyond
human error to identify system issues that could contribute to errors. Based on the
outcome of RCA, medical laboratories can implement precautionary action to prevent the
errors from recurring. Participants from Company A explained that they use a form to
track their samples. If an error occurs, they refer to the form and analyze for the root
cause of the error. They analyze each case individually to determine the root cause. The
main methods in use are examining documentations, interviewing the staff, and observing
them as they complete their tasks. Company B mentioned that when an error occurs, they
review the workflow to determine the error. Reviewing the workflow might expose the
cause of error as systematic or personal. Company B uses the 5 Whys to expose the root
cause of error. Both companies developed preventive actions based on the root cause of
the error. Implementation of precautionary actions helps both companies prevent errors
from recurring. Preventive actions have the ability to reduce rework, minimize waste,
and increase operating margin. Both companies involve their staff in the in the
implementation of preventive and corrective actions because they are the frontline staff
and are more knowledgeable with the preanalytical processes.
International Organization for Standardization 15189 specified that laboratories
must review their procedures regularly to identify sources of nonconformities and
opportunity for improvement (Allen, 2013). The studied cases emphasized that they
assessed their standard operating procedures (SOPs) on a continuous basis to ensure that
practice matched the written procedures. The SOPs should define all steps involved in
the preanalytical phase and these procedures should be available to all staff. Another
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requirement is the training of all staff to these procedures. These practices are effective
in creating quality standards in terms of the processes followed by the staff members,
creation of well-defined procedures, training, and improving skills and competencies of
staff members.
Another element that TQM and ISO 15189 require organizations to meet is the
engagement and empowerment of all stakeholders in the development and
implementation of process improvement. The two studied cases agreed that patient
satisfaction is the focus of their businesses. To achieve patient satisfaction, TQM
requires organizations to produce quality service. Successful implementation of TQM
requires the involvement of all stakeholders. Empowering employees in the
development and implementation of TQM encourages employees to express their ideas
and allowed them to implement process improvements. Both companies emphasized the
need to involve all stakeholders when implementing TQM initiatives. Engaging
employees in the root cause analysis and implementation of preventive actions produces
better outcomes. The employees are frontline workers and are more knowledgeable of
the preanalytical processes. Engaging staff to assess and implement ideas to improve
quality results in them feeling appreciated and rewarded. As a result, a happier and
productive workforce will ensue. Without this element, implementing TQM will be less
successful.
Results obtained from this study correlate with the conceptual framework of
TQM. Patient satisfaction is the echoing theme among all participants in both cases
under study. Company A and B use this framework to gather data, analyze data, and
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diagnose the source of errors. In addition, both organizations engaged their workforce in
diagnosing the errors and in implementation of preventive and or corrective actions. The
current study examined the strategies used by medical laboratory managers to minimize
preanalytical errors. Strategies used to minimize preanalytical errors aligned with quality
management. Total Quality Management provides the framework for the studied
organizations to concentrate and promote a quality culture. Providing quality service will
lead to improved patient satisfaction, and organizations can gain and retain their market
share of customers. Participants in Company A and Company B explained that patients
or providers have many choices when receiving health care services. If they are not
happy with the service they received, they will take their business elsewhere. Providing
quality service will help medical laboratories gain competitive advantages over their
competitors. A comprehensive TQM is the most effective strategy to lessen laboratory
errors (Hammerling, 2012). By incorporating TQM aspects into the practices shared by
the managers in the study, organization will benefit from the foreseen effects of reduced
operational costs, improved financial performance, increased patient care experience, and
increase job satisfaction with the staff.
Applications to Professional Practice
The purpose of this qualitative multiple case study was to identify strategies used
by medical laboratory managers to mitigate preanalytical errors. Patient safety is an
ongoing challenge in health care delivery (Cornes et al., 2016b). As an integral part of
health care, medical laboratories contribute to this challenge. Accurate laboratory results
are imperative in the diagnostic and efficiency of treatment of patients (Gupta, Yadav,
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Mishra, & Sharma, 2015). Laboratory testing is divided into three phases: preanalytical,
analytical, and post analytical (Cornes et al., 2016a). Errors can occur in any phase of
testing, but the most prevalent is in the preanalytical phase with error rates up to 70%.
Preanalytical errors include, but are not limited to, the following processes: test order, test
request, sample collection and transport, and sampling. Preanalytical errors contribute to
overall diagnostic and therapeutic errors (Cornes et al., 2016b). Although laboratories
have to go through rigorous quality assessments by accreditation bodies, errors in the
preanalytical phase continue to exist. Efforts made by organizations such as the
European Federation of Clinical Chemistry and Laboratory Medicine Working Group for
Preanalytical Phase (EFLM WGPRE) tried to mitigate these errors. As a part of
contributing efforts, this study aimed to identify and expose strategies used by medical
laboratory managers to reduced preanalytical errors.
The findings from this multiple case study could contribute to the health care
industry in terms of reducing the laboratory errors in the preanalytical phase given that
the current study readily offers effective and evidenced practices by medical laboratory
managers. Overall, healthcare companies and their consumers should both benefit from
the practices and methods presented in the current study. The applications of the findings
take patients’ lives into consideration by looking more in-depth into the recommended
practices of the managers who participated in this study.
Laboratory errors affect patient safety (Plebani et al., 2013a), cost millions of
dollars, and could cause detrimental effects for their patients (Favalaro et al., 2012). The
current study concurs with findings from the researchers mentioned above. Healthcare
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companies should gain insights from the practices that worked for Companies A and B in
streamlining their management of laboratory processes and policies. This should allow
healthcare companies to experience even more positive social outcomes in terms of their
business and financial goals. For consumers, they will receive an improved quality of
care from their health companies. The literature indicates that deaths resulting from
medicinal faults are the eighth foremost cause of death in the United States. By
following the meaningful and effective methods and practices shared by all five managers
of the two companies analyzed, these numbers should decrease over time.
Implications for Social Change
From the findings of the study, healthcare companies are still very much
committed to serving their consumers with the best quality of service and care that they
can. The attitude portrayed by the managers should create a positive impression for
healthcare companies that are often perceived as focusing merely on their business and
financial concerns; while neglecting the human aspect of the practice. The study should
serve as evidence that managers and their companies value their consumers and patients.
The mindset displayed by these managers should also inspire and motivate other big and
small healthcare companies to follow in these two companies’ footsteps to start
restructuring their companies with the goal of balancing the financial and human aspects
of the business.
Another social change noted was the focus on constant improvement by the
external and internal members of the healthcare companies. The companies in this study
targeted the growth of their staff members and employees to reduce the preanalytical
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laboratory errors. By learning and being more skillful in their tasks, staff members
gained more experience and knowledge personally and professionally. Strengthening the
capabilities of staff members should then improve the proper care provided to patients.
The outcomes of this study add to the body of research for minimizing preanalytical
errors. Thus, individuals from both inside and outside these healthcare companies should
experience positive changes.
Recommendations for Action
All health care providers should view preanalytical errors as a serious problem
because laboratory results influence approximately 70% of clinical decisions (Abdollahi
et al., 2014). Results from this study provide medical laboratory leaders with strategies
to mitigate the occurrence of preanalytical errors. Successful strategies used by the
participants included employee engagement, reward and recognition program, and
training and education.
Healthcare companies can consider the examination of the root causes of the
problems first through careful documentation and observation of the problems. Also,
healthcare companies can focus on the assessment of their employees and staff members
to determine if the problems or issues are coming from them. Healthcare companies and
their managers can consider focusing on the knowledge and skill improvement of their
staff. By doing so, their staff members gain the tools and equipment to perform their
tasks and responsibilities in the laboratory. The increased education of the staff should
address laboratory errors experienced by the companies in the preanalytical phase.
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Lastly, healthcare companies can implement employee recognition and engagement
programs to reduce laboratory errors in the preanalytical phase.
Medical laboratory leaders can review and apply effective strategies to assist with
the reduction of preanalytical errors in their medical laboratory. Any successful
implementation of strategies to decrease errors in the preanalytical phase will result in
better delivery of patient care. Leaders in health care delivery will view the reduction of
these errors as a competitive advantage. By reducing these errors, patient satisfaction and
retention will increase while operational cost will decrease.
Findings from this study add to the existing knowledge of preanalytical errors.
My intent is to disseminate this information through various forums. I will provide a
summary of the findings to all participants and ask them to share the information with
their peers and colleagues. Another way to publicize the successes of the participants is
through the publication of this study in ProQuest/UMI dissertation database. Interested
audience can retrieve this information through this database. Also, I will seek for
opportunities to broadcast this information through medical laboratory conferences,
seminars, and academia settings.
Recommendations for Further Research
In this multiple case study, I exposed strategies used by medical laboratory
managers to reduce preanalytical errors. The findings from two medical laboratories
added to the limited research found in the existing literature pertaining to this topic. For
future research, scholars can consider three recommendations to improve their research
studies. First, researchers can consider employing a mixed-method study. The mixed-
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method study would support the qualitative findings through the inclusion of the statistics
on the laboratory errors in the preanalytical phase that occurred in the respective
companies over the years. By triangulating the findings from the interviews and the data
from the records, the researchers could provide evidence on whether the methods and
practices they implement are effective or ineffective.
Second, researchers could consider increasing the number of participants in the
interviews and expanding the geographical location to discover more themes as well as
providing more meaningful insights from more participants. The population size of five
medical laboratory managers at two health care organizations in southern California does
not represent an all-inclusive view of strategies used to minimize preanalytical errors.
Future study should consider a larger group of health care providers to determine the
effectiveness of the strategies used by the participants. Expanding the geographical
location might reveal different results from health care organizations that operate under
different culture and environment conditions. Evaluating strategies used by medical
laboratory managers beyond the defined geographical location may increase the ability of
laboratory industry and other ancillary entities to minimize these errors. Limiting the
defined geographical location also restricts the generalizability of the findings.
Last, the researchers could consider increasing the generalizability of the study by
recruiting other preanalytical staff members. The targeted population of medical
laboratory managers does not represent the involvement of all health care professionals in
the preanalytical phase of testing. Understanding other health care professionals’
perceptions, including clinicians, couriers, phlebotomists, laboratory assistants, and
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clinical laboratory scientists, may expose strategies used by these individuals to minimize
preanalytical errors. Therefore, a wider sample population that includes participants from
other geographical locations and involvement of other health care professionals has the
potential to increase validity, decrease selection bias, and fewer data anomalies.
Reflections
As I reflect on my journey with the DBA Doctoral Study process, I realized that
this experience helped me grow as a student and professional aiming for lifelong
learning. With the encouragement of Walden faculty, I was able to choose a topic that
met the criteria of the DBA Doctoral Study. This encouragement enabled me to work
through the many frustrations that arose along the way and to remain engaged until the
completion of the DBA Doctoral Study.
Prior to considering this topic, I read many journal articles on the topic of
laboratory errors. Narrowing the topic to preanalytical errors enabled me to focus sharply
on the most problematic area of total laboratory testing. Further refining of the topic to
strategies used by laboratory managers to mitigate laboratory errors provided a laser
emphasis of possible solutions to the problem.
My interest in this phenomenon stemmed from my profession. Serving as
medical laboratory manager and quality assurance manager, I often found it frustrating
and disheartened to experience the effects of laboratory errors; misdiagnoses, delay of
treatment, and increased operational costs. Choosing to concentrate on strategies used by
medical laboratory managers to curb preanalytical errors allowed me to conduct the study
without biases. I was able to collect and analyze data without biases because I do not
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have any experience in the preanalytical phase of testing. Therefore, I was able to
conduct the study without any preconceived knowledge of the responses to the interview
questions.
The focus of this study was to explore strategies used by medical laboratory
managers to successfully curb preanalytical errors. Although each participant revealed
different perceptions, there were several strategies shared among the participants in their
efforts to reduce these errors. The strategies exposed in this study enabled me to gain a
deeper comprehension of laboratory medical managers’ abilities to minimize
preanalytical errors. Laboratory leaders can use the findings in this study to help them
analyze and implement strategies to decrease preanalytical errors.
Conclusion
This research presented the processes of the two companies who have succeeded
in reducing their laboratory errors in the preanalytical phase. Through the study,
practices and methods were established which should aid other companies and medical
practitioners in addressing their problems of the same type. The findings were important
to identifying the root causes through careful and proper documentation of specimens and
other resources. The main emphasis of the managers revolved around the need for staff
members and personnel to be involved at all times; giving them value by constantly
training and educating them to be equipped with the skills of determining and managing
the errors strategically. Finally, the managers and their companies highlighted the
importance of reducing laboratory errors to providing their consumers with the best
service and quality care that they deserve. These findings indicate that with enough
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effort and commitment from healthcare companies, their management, and staff
members, more and more patients’ lives can be saved. As companies try to improve their
preanalytical practices and processes, patients also feel the values on the lives placed by
these companies. In the end, and with proper application of the suggested methods, it is
hoped that concrete and actual changes in patients’ lives will be achieved.
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Appendix A: Recruitment Letter
Subject: Invitation to Participate in a Doctorate Study
Date: [Insert Date]
Dear Sir/Madam:
My name is Huong Ly and I am a student at Walden University, pursuing a Doctor of
Business Administration degree (DBA). My credentials include over ten years as a
clinical laboratory scientist performing assay analysis. In addition, I also have over five
years of management experience, of which three are in quality assurance. I am
conducting a case study in southern California exploring the success of medical
laboratory managers with minimizing laboratory errors. The title of my study is
“Exploring Medical Laboratory Managers Success with Preanalytical Errors.” I would
like to explore ways to help other laboratories reduce errors in this phase of testing. It is a
fact that many laboratories encounter this relevant issue. Numerous researchers and
practitioners cited up to 75% of errors occur in the preanalytical phase of testing. I would
like to interview medical laboratory managers who meet the following criteria:
• Organization must be located in southern California.
• Laboratory manager must have a minimum of five years of laboratory experience.
• Laboratory manager must have at least two years of management experience with
preanalytical process.
• Laboratory manager must have completed at least one project to minimize laboratory
errors.
I will be the data collector and the data collection method is through face-to-face
interview and observation of your preanalytical process. Rest assured that all divulged
information will be anonymous and I will not share your data with other health care
organizations. Note that there is a lack of incentive if you decide to partake in this study.
If you meet the criteria and would like to participate in this study, my contact information
is (714) 595-1389 or huong.ly@waldenu.edu. Thank you for your consideration.
Sincerely,

Huong Ly
DBA Student
Walden University
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Appendix B: Consent Form
This is a research project being conducted by Huong Ly at Walden University. You are
being asked to participate in a research study exploring your success with preanalytical
errors. I am asking you to partake in this study because you are a medical laboratory
manager with successes at curbing error in this phase of testing. Please read this form
carefully before agreeing to take part in the study.
Voluntary: Your participation in this research study is voluntary. You have the option to
not participate or withdraw without reprisal at any point of the study. You can withdraw
either through an email or verbal request. You can email me at huong.ly@waldenu.edu
What the study is about: The purpose of this qualitative case study is to explore in
depth how medical laboratory managers reduce laboratory errors in the preanalytical
phase. Participants for this case study are medical laboratory managers who reduced
laboratory errors in the preanalytical phase.
What we will ask you to do: If you agree to be in this study, you will complete a faceto-face interview at the organization where you work. Each interview will take about 60
minutes to complete. The interview questions revolve around your knowledge and
success with the preanalytical errors. I will also need to spend about 30 minutes
observing your preanalytical processes. In addition, I will need to spend an additional 30
minutes with you to review the collected data to validate the findings.
Risks and benefits: There is the risk that you will find some of the questions about your
job conditions to be sensitive. There are no benefits to you. Laboratory work is very
demanding and keeping errors to a minimum is critical. I hope to learn more about ways
to minimize preanalytical errors that affect patient safety and health.
Compensation: There is no compensation for taking part in this study.
Confidentiality: I will not collect identifying information such as your name, email
address, or IP address. In any type of report I make public, I will not include any
information that will make it possible to identify you or your organization. All data is
stored in a password protected electronic format. This consent form and study data will
be in the researcher’s possession for five years locked in a personal safe deposit box, then
destroyed upon the expiration of the timeframe. The results of this study will be used for
scholarly purposes only and may be shared with Walden University representatives or
other health care facilities.
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Contact information: If you want to talk privately about your rights as a participant, you
can call Dr. Leilani Endicott. She is the Walden University representative who can
discuss this with you. Her phone number is 612-312-1210. This research has been
reviewed according to Institutional Review Board (IRB) procedures for research
involving human subjects. The Walden IRB approval number for this study is
XXXXXXXXX.
Statement of Consent: I have read the above information and acknowledge that by
signing this consent form, I decided to partake in this study. I agree to terms outlined
above.
___________________________
Printed Name of Participant

_______________________
Date of consent

________________________
Participant’s Signature

______________________
Researcher’s Signature
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Appendix C: Data Collection Instrument – Interview Guide
The interview questions are:
1. How do you identify the areas that are the focus of preanalytical errors?
2. How do you diagnose the root cause of the problem? Do you use observations
and documentation to help diagnose the root cause?
3. How do you implement interventions that could potentially yield favorable
outcomes to minimize errors?
4. How do you reinforce the identified inventions to ensure effectiveness?
5. Does your organization consider quality as a top priority?
6. What is your strategy to engage employees in developing a quality culture?
7. How do you involve and empower all laboratory and other ancillary personnel
in cooperative efforts to achieve quality improvements in the preanalytical
phase?
8. How can quality improve operational costs, patient care experience, and
competitive advantage?
9. How do you implement continuous improvement of employee’s capabilities
and work processes through training and education to reduce preanalytical
errors?
10. Is there any other preanalytical error reduction strategy you would like to
share to help medical laboratory managers address this issue?
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Appendix D: Observation Protocol
Date: __________________________________________
Time: __________________________________________
Place: __________________________________________
Descriptive notes
Phlebotomy (patient identification,
phlebotomy procedure, specimen labeling)

Specimen tracking

Specimen transportation

Specimen rejection

Reflective notes

